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SUMMARY 
 
Summary 
Secondary metabolites originated from plants, bacteria and fungi constitute a large 
group of compounds, which are not directly related to the growth, development and 
reproduction of the organism. However, the producer can benefit from these metabolites 
to defend itself against natural enemies, competitors or environmental pressure. 
Furthermore, they often exhibit useful and interesting biological and pharmaceutical 
activities, which provide benefits to human health and life. For example, cyclodipeptides 
(CDPs) and their derivatives have gained increasing attention for their interesting and 
diverse pharmaceutical activities. Natural CDPs are mainly formed by nonribosomal 
peptide synthetases (NRPSs) or cyclodipeptide synthases (CDPSs). The CDP cores 
resulted from the NRPS or CDPS pathways are often further modified by varieties of 
tailoring enzymes leading to the formation of sophisticated natural products. The small 
size of CDPSs (200−300 residues) makes them genetically easily manipulated in 
synthetic biology. 
In the first project of this thesis, a cooperation project with Jing Liu, nine new CDPS 
genes from eight Streptomyces strains were functionally characterized after cloning into 
pET28a vector and expressing in E. coli. The products were analyzed on LC-MS and 
then isolated for NMR analysis. The products were identified as tryptophan-containing 
cyclodipeptides (cWXs) that are the most common precursors of diketopiperazines 
(DKPs) with pharmaceutical interest, due to the various modification possibilities on the 
indole ring. The nine identified CDPSs include six specific CDP synthases consisting of 
one cWL synthase, two cWP synthases and three new cWW synthases as well as three 
unspecific CDPSs producing several products with cWA or cWY as the major 
cyclodipeptide. Total product yields of CDPs were calculated based on HPLC analysis 
to be 46 to 211 mg/L E. coli culture. Our findings represent rare examples of cWXs 
derived from CDPS pathways in actinobacteria. This study also provides a valid 
experimental basis for further combination of CDPSs with other tailoring enzymes in 
biosynthesis of interesting compounds.    
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The three identified cWW synthases from Streptomyces purpureus NRRL B-5737, 
Streptomyces lavendulae NRRL B-2774, and Streptomyces xanthophaeus NRRL B-
5414 are genetically associated with a putative cytochrome P450. The three P450 
homologues share sequence identities of more than 75% with each other on the amino 
acid level, indicating same or very similar function. As a representative, the function of 
P450NB5737 from S. purpureus was identified by heterologous expression in 
Streptomyces coelicolor and in vitro assays with the recombinant protein produced in E. 
coli. Isolation and structure elucidation confirmed that P450NB5737 catalyzes the transfer 
of a guanine moiety onto the indole ring of cWW via a C–N bond, leading to 
unprecedented adducts of cyclodipeptide with a nucleobase. This represents one 
additional example of rare P450 enzymes catalyzing the coupling of two different 
substrates. 
Besides CDPs, prenylated aromatic products often possess various biological and 
pharmacological activities, in comparison to their non-prenylated precursors. The 
prenyltransferases of the DMATS superfamily show broad flexibility toward aromatic 
substrates, but relatively strict prenyl donor tolerance. They usually accept only DMAPP, 
but not GPP or other prenyl donors with a longer chain length. To broaden the prenyl 
donor spectra, the acceptance of tyrosine O-prenyltransferases TyrPT and SirD towards 
unnatural DMAPP analogs such as MAPP, 2-pen-PP, and benzyl-PP was tested in the 
presence of tyrosine and its derivatives. The results revealed that TyrPT and SirD also 
use the unnatural donors and exhibit similar behavior as their natural prenyl donor 
DMAPP. Alkylated or benzylated products at the same positions of that with DMAPP 
have therefore been identified. This study increased significantly the diversity of 
prenylated products by chemoenzymatic synthesis. 
The results presented in this thesis contributed significantly to the formation and 
metabolism of tryptophan-containing CDPs in nature and expanded the potential 
application of prenyltransferases. They provide a solid basis for applications in the 
synthetic biology in the future.  
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Zusammenfassung 
Sekundärmetabolite aus Pflanzen, Bakterien und Pilzen stellen eine große 
Substanzklasse dar, die nicht direkt mit Wachstum, Entwicklung und Reproduktion des 
Organismus zusammenhängen. Jedoch kann der Produzent sich diese Metaboliten zu 
Nutze machen, um sich vor natürlichen Feinden, Konkurrenten oder Umwelteinflüssen 
zu schützen. Darüber hinaus weisen sie oft nützliche und interessante biologische und 
pharmazeutische Aktivitäten auf, wovon die menschliche Gesundheit und das Leben 
profitieren können. Zum Beispiel haben zyklische Dipeptide (CDPs) und ihre Derivate 
an zunehmender Aufmerksamkeit in Bezug auf ihre interessanten und vielfältigen 
pharmazeutischen Aktivitäten gewonnen. Natürlich vorkommende CDPs werden in der 
Regel von nichtribosomalen Peptidsynthetasen (NRPSs) oder Cyclodipeptidsynthasen 
(CDPSs) gebildet. Die von der NRPS- oder CDPS-Synthesewege gebildeten CDP-
Grundstrukturen werden häufig mithilfe von verschiedenen „Tailoring enyzmes“ weiter 
modifiziert, sodass komplexere Naturstoffe entstehen. Wegen ihrer geringen Größe 
(200–300 Aminosäuren) können CDPSs gentechnisch leicht manipuliert werden. 
In dem ersten Projekt dieser Arbeit, einem Kooperationsprojekt mit Jing Liu, wurden 
neun neue CDPS-Gene aus acht Streptomyceten-Stämmen jeweils in einen pET28a 
Vektor kloniert und in E. coli exprimiert. Die Produkte wurden mittels LC-MS analysiert 
und anschließend für die Strukturaufklärung isoliert. Die Produkte wurden als zyklische 
Dipeptide mit einer Tryptophaneinheit (cWXs) identifiziert. Diese sind pharmazeutisch 
besonders interessant, da sie vielseitig am Indolring modifiziert werden können. Sechs 
der neun identifizierten CDPSs sind spezifische CDP-Synthasen, davon eine cWL 
Synthase, zwei cWP Synthasen und drei neuen cWW Synthasen, sowie drei 
unspezifische CDPSs, die cWA oder cWY als Hauptprodukt, bilden. 
Die Gesamtmenge an produzierten CDPs von 46 bis 211 mg/L in E. coli Kultur wurde 
mittels HPLC berechnet. Unsere Ergebnisse repräsentieren seltene Beispiele an cWXs, 
die aus den CDPS-Synthesewegen von Actinobakterien hervorgehen. Diese Arbeit 
liefert auch eine valide experimentelle Grundlage für weitere Kombinationen von 
CDPSs mit anderen modifizierende Enzymen in der synthetischen Biologie. 
Die drei identifizierten cWW-Synthasen aus Streptomyces purpureus NRRL B-5737, 
Streptomyces lavendulae NRRL B-2774 und Streptomyce xanthophaeus NRRL B-5414 
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sind genetisch mit putativen Cytochrom P450 Enzymen assoziiert. Die drei P450 
Homologe weisen untereinander eine Identität der Aminosäuresequenz von mehr als 75% 
auf, was auf die gleiche oder eine sehr ähnliche Funktion hindeutet.  
Als repräsentativer Vertreter der drei P450s wurde die Funktion von P450NB5737 aus 
S. purpureus durch heterologe Expression in Streptomyces coelicolor, sowie mithilfe 
von in vitro Assays mit dem rekombinanten Protein untersucht. Die Übertragung einer 
Guanineinheit auf den Indolring von cWW mit Ausbildung einer C–N-Bindung durch 
P450NB5737 wurde nach Isolierung und anschließender Strukturaufklärung bestätigt. 
Diese Verknüpfung stellt die Katalyse eines noch nie nachgewesenen Addukts 
zwischen einem zyklisches Dipeptid mit einer Nukleinbase dar. Dies ist ein weiteres 
Beispiel von seltenen P450 Enzymen, welche die Verknüpfungen zwei unterschiedlicher 
Substrate katalysierten. 
Im Vergleich zu ihren nicht prenylierten Vorläufern, zeigen prenylierte aromatische 
Produkte oft diverse biologische und pharmazeutische Aktivitäten. Die 
Prenyltransferasen der DMATS-Superfamilie sind ihren aromatischen Substraten 
gegenüber sehr flexibel, allerdings weisen sie ihrem Prenyldonor gegenüber nur eine 
geringe Toleranz auf. In der Regel akzeptieren sie nur DMAPP, jedoch nicht GPP oder 
andere Prenyldonoren mit einer noch längeren Kettenlänge. Um das Spektrum des 
Prenyldonors zu erweitern, wurde die Akzeptanz von zwei Tyrosin-O-
Prenyltransferasen TyrPT und SirD gegenüber unnatürlichen DMAPP Analoga wie 
MAPP, 2-pen-PP und Benzyl-PP in Anwesenheit von Tyrosin und Derivaten getestet. 
Die Ergebnisse zeigten, dass TyrPT und SirD auch die Übertragung der unnatürlichen 
Donoren katalysieren und dabei ein ähnliches Verhalten wie mit dem natürlichen 
Prenyldonor DMAPP beibehalten. Produkte, die die Alkyl- bzw. Benzylgruppe an 
denselben Positionen wie mit DMAPP tragen, wurden daher identifiziert. Diese Arbeit 
trägt erheblich zur Vielfalt von prenylierten Produkten durch chemoenzymatische 
Synthese bei. 
Die Ergebnisse dieser Dissertation tragen maßgeblich zur Bildung und zum 
Metabolismus von tryptophanhaltigen CDPs in der Natur bei, sowie die Erweiterung 
potenzieller Anwendungen von Prenyltransferasen. Darüber hinaus bilden sie eine 
solide Grundlage für zukünftige Anwendungen in der synthetischen Biologie.  
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1 Introduction 
1.1 Actinobacteria 
Actinobacteria is one of the largest phyla of Domain Bacteria. It contains gram-positive 
bacteria with high guanine-cytosine (GC) content from 51% to over 70% in their DNA, 
with some exceptions of less than 50% G+C1,2. They are widely distributed in both 
terrestrial and aquatic habitats3. Containing most members of economic or medical 
significance, the order of Actinomycetales often grows extensive mycelia and can be 
reproduced by spores or hyphae. Behaving like fungi as decomposer in soil, they exhibit 
economic importance for agriculture and forests. Actinomycetes also play important 
roles in drug discovery and contribute to 61% of all microorganism-derived bioactive 
compounds so far discovered4. Two-thirds of known antibiotics in current use are 
originated from actinomycetes, with Streptomyces as the main source4,5. Since the 
discovery of streptomycin from Streptomyces griseus in 1943, numerous antibiotics and 
their derivatives within different chemical classes such as β-lactams, tetracyclines, 
aminoglycosides, macrolides, and glycopeptides have been discovered in 
actinomycetes and used clinically in modern medicine for treatment of different 
diseases6. However, the increasing occurrence of antibiotic-resistant pathogenic 
organisms7 and the remarkable decline in discovery of novel antimicrobial agents8 make 
the public heath confront with great challenges. To solve the antibiotic-resistance 
problem and identify more bioactive compounds, intensive researches on novel 
approaches for natural product discovery have been performed in recent decades. One 
strategy is to activate silent or cryptic gene clusters of secondary metabolites by the 
induction in vivo or heterologous expression in engineered Streptomyces host with clear 
background9. Other efforts include exploiting rare actinomycetes in extreme habitats, 
metagenomics analysis of uncultured environmental samples, improvement of analytical 
methods10, and elicitation of secondary metabolite with biological, chemical and 
molecular strategies11.  
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1.2 Cyclodipeptides 
Cyclodipeptides (CDPs) and their derivatives constitute a large class of secondary 
metabolites with potential biological and pharmacological activities12,13. For instance, 
cyclo-L-His-L-Tyr (1) and cyclo-L-His-L-Phe (2) could be employed as antiarrhythmic 
agents14. Compound 2 and its derivative phenylahistin (3) show significant antitumor 
activity14,15. cyclo-L-Phe-L-Pro (4) and cyclo(L-Phe-trans-4-OH-L-Pro) (5) act as 
antifungal agents16. cyclo-L-Leu-L-Pro (6) and echinulin (7) inhibit mycobacteria17,18. 
cyclo-L-His-L-Pro (8) and cyclo(dehydroala-L-Leu) (9) represent antihyperglycaemic 
agents19,20 and 8 also exerts anti-inflammatory effects (Figure 1)21. The main structure 
of CDPs are generated by the condensation of two α-amino acids, which can be 
achieved through total chemical synthesis or biosynthesis catalyzed by two groups of 
enzymes, non-ribosomal peptide synthetases (NRPSs) and cyclodipeptide synthases 
(CDPSs), in nature13. 
 
 
Figure 1. Selected examples of cyclodipeptides and derivatives with pharmacological 
activities. 
  
1.2.1 CDPs from NRPS pathways 
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Non-ribosomal peptide synthetases (NRPSs) are large multimodular enzymes that 
assemble complex peptides with diverse structures and biological activities in 
microorganisms such as bacteria and fungi22. In the single polypeptide chain of NRPS 
lies an array of large, repetitive modules and each module comprises several catalytic 
domains. As shown in Figure 2, one elongation module contains at least three domains, 
adenylation (A), thiolation (T), and condensation (C) domain. The initiation module has 
no C domain and the termination module has an additional thioesterase (TE) domain. 
The non-ribosomal peptides (NRPs) assembly initiates with the activation of the amino 
acid substrate resulting in an aminoacyl-AMP intermediate under the catalysis of A 
domain. The first activated intermediate is then transferred to the thiol group tethered of 
T domain and condensed with the second intermediate bound to the adjacent T domain 
to form the peptide bond, which is catalyzed by C domain. After condensation with the 
last amino acid, the final product is released by hydrolysis or cyclization catalyzed by TE 
domain23. Different to the normal ribosomal-dependent synthesis  
Figure 2. Model of NRPs biosynthesis. (Modified from review 23) 
Initiation module
Elongation module
Termination module
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machinery that incorporates only the proteinogenic amino acids, NRPSs can catalyze 
additionally the assembly of hundreds of other building blocks like D- and β-amino acids, 
α-keto- and α-hydroxy acids and even heterocycles and fatty acids24, which increases 
significantly the structural diversity of natural products. The biosynthetic origins of many 
CDP-containing natural products in fungi and some bacteria are catalyzed by NRPSs, 
through dedicated biosynthetic pathways (bimodular NRPS) or through premature 
release of dipeptidyl intermediates as side CDP products during the biosynthesis of a 
larger peptide by NRPSs25-27. Several bioactive compounds such as thaxtomin 
(10)25,28,29, roquefortine C (11)/meleagrin (12)30, gliotoxin (13)31, fumitremorgin (14)32, 
acetylaszonalenin (15)33, and ditryptophenalaine (16)34 (Figure 3) are products of NRPS 
pathways, and the core CDPs are catalyzed by bimodular NRPSs.  
 
Figure 3. Selected examples of CDP-containing bioactive compounds generated by 
NRPS pathways. 
 
1.2.2 CDPs from CDPS pathways 
In addition to NRPSs, the characterization of AlbC in 2002, an NRPS-unrelated enzyme 
able to specifically form CDPs by hijacking aminoacyl-tRNAs (aa-tRNA) as substrates in 
the albonoursin pathway in Streptomyces noursei, revealed a new enzyme family 
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named cyclodipeptide synthases (CDPSs), which started a new era in the investigation 
on biosynthesis of cyclodipeptides35,36. Subsequently, several CDPSs from different 
organisms were identified to form varieties of CDPs37. Benefiting from the steadily 
increasing number of complete or partial genome sequences available since 200538, 
more than one hundred CDPSs have been experimentally characterized so far, 
incorporating 18 of the 20 proteinogenic amino acids into cyclodipeptides, with the 
exception for Asp and Lys37,39-42. In contrast to the large NRPSs, CDPSs are small 
peptide bond–forming enzymes with typical polypeptides of 200–300 amino acid 
residues39. They were found to be mostly distributed in the Actinobacteria, 
Proteobacteria and Firmicutes, with only a few were identified in eukaryotes37,39,43.  
To investigate the catalytic mechanism of CDPSs, crystal structures of three CDPSs, 
AlbC from S. noursei, Rv2275 from Mycobacterium tuberculosis and YvmC from 
Bacillus licheniformis, have been solved44-47. It was proposed that CDPSs used a ping-
pong mechanism to catalyze the formation of CDPs by hijacking aa-tRNAs from primary 
metabolism as substrates (Figure 4)37. The reaction begins with binding of the first aa-
tRNA, followed by the transfer of its aminoacyl moiety onto the conserved S37 (AlbC 
numbering) of the enzyme pocket. The resulted aminoacyl enzyme intermediate 
subsequently reacts with the aminoacyl moiety of the second aa-tRNA leading to 
formation of the dipeptidyl enzyme intermediate. Then the second peptide bond is 
formed by intramolecular cyclization thus generating the final CDP37. 
During the formation of CDP, the catalytic residues S37, N40, Y178, E182, Y202 and 
H203 play important roles in catalysis via hydrogen bond formation or deprotonation of 
ammonium group for nucleophilic attack47. Based on the distinguished conserved 
residues at position 40 and 203 and the highly conserved Y202 within the active sites, 
CDPSs are classified into three subfamilies, NYH, SYQ and XYP subfamiliy39. CDPSs 
can also incorporate non-canonical amino acids (ncAAs) into CDPs by loading the 
ncAAs to tRNAs using the promiscuity of aminoacyl-tRNA synthetases, which breaks 
the limitation of potential precursors to the 20 proteinogenic amino acids and diversifies 
CDPS products significantly48. Until now, several bioactive compounds derived from the 
CDPS pathways have been described, for instance, albonoursin (17)35,36, cWW-Me2 
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(18)49, pulcherriminic acid (19)45,50, mycocyclosin (20)51,52, nocazine E (21)/neihumicin 
(22)53, bicyclomycin (23)54,55, and dehydrophenylahistin (24)56 (Figure 5). 
 
 
Figure 4. Proposed mechanism for cyclodipeptide biosynthesis by CDPS37. 
 
 
Figure 5. Selected examples of CDP-containing bioactive compounds generated by 
CDPS pathways. 
1.2.3 CDP tailoring enzymes 
In the CDP-containing natural product biosynthesis, the initially assembled CDPs by 
CDPSs or NRPSs are usually further modified by the associated tailoring enzymes 
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(Scheme 1). In the CDPS pathways, a variety of putative enzyme classes can be found 
genetically associated with respective CDPS gene. These include numerous oxidative 
enzymes of different types of cytochromes P450, α-ketoglutarate/FeII-dependent 
dioxygenases (α-KGDs) and flavin-containing monooxygenases. A large number of 
different O-, N-, and C-methyltransferases, α/β-hydrolases, peptide ligases, and acyl-
CoA transferases also belong to the CDP tailoring enzymes57. Among the modifying 
enzymes, cyclic dipeptide oxidases (CDOs), a family of novel flavin-dependent amino 
acyl α,β-dehydrogenases, are widely distributed in the CDPS pathways and show 
extensive substrate specificity35,36,53. NRPS-dependent pathways contain similar types 
of modification enzymes, with the distinguishing feature of wide presence of a range of 
prenyltransferases catalyzing regular or reverse prenylation at different positions of the 
CDP scaffold58,59. The tailoring enzymes involved in the biosynthesis of selected CDP-
containing natural products from NRPS and CDPS pathways are summarized in Table 1 
and Table 2, respectively.  
By using synthetic biology, combinatorial expression of tailoring enzymes originating 
from unrelated biosynthetic pathways provides the possibility to produce newly modified 
CDPs with diverse structures. For example, dehydrophenylahistin (24) is transformed by 
CDO-containing cell-free extract of Streptomyces albulus KO-23 from the fungal 
metabolite phenylahistin (3), resulting in more than 1000 times higher cytotoxicity than 
phenylahistin56. Among the CDP modifying enzymes, cytochromes P450 play important 
roles in natural product biosynthesis via diverse oxidative reactions. 
  
Scheme 1. Different kinds of modifications of CDP generated by CDPS or NRPS. 
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Table 1. Overview of different tailoring enzymes associated within gene clusters of the 
NRPS pathways. 
 
Compounds 
(Producer) 
CDP Core Tailoring Enzymes (Function) 
thaxtomin A (10) 
(Streptomyces scabies) 
cWF cytochrome P450 (hydroxylation) 
roquefortine C(11)/ 
meleagrin (12) 
(Penicillium chrysogenum) 
cWH prenyltransferase (C3-reverse prenylation) 
methyltransferase (O-methylation) 
cytochrome P450 (oxidative cyclization) 
N-hydroxylase (N-hydroxylation) 
oxidoreductase (α,β-dehydrogenatioin) 
gliotoxin (13) 
(Aspergillus fumigatus) 
cFS 
 
two cytochromes P450 (oxidation) 
glutathione S-transferase (sulfurization) 
aminocyclopropane carboxylic acid synthase 
(cyclopropane-formation) 
two methyltransferase (O- /N-methylation) 
fumitremorgin B (14) 
(Aspergillus fumigatus, 
Neosartorya fischeri) 
cWP 
 
two prenyltransferases (N- /C2-prenylation) 
three cytochrome P450 (oxidative 
cyclization, hydroxylation) 
methyltransferase (O-methylation) 
acetylaszonalenin (15) 
(Neosartorya fischeri) 
cWF 
 
prenyltransferase (C3-reverse prenylation) 
acetyltransferase (N-acetylation) 
ditryptophenalaine (16) 
(Aspergillus fumigatus) 
cWF cytochrome P450 (dimerization) 
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Table 2. Overview of different tailoring enzymes associated within gene clusters of the 
CDPS pathways. 
Compounds CDP Core Tailoring Enzymes (Function) 
albonoursin (17) 
(Streptomyces noursei)   
cFL CDO (α,β-dehydrogenation) 
cWW-Me2 (18) 
(Actinosynnema mirum) 
cWW methyltransferase (N-methylation) 
pulcherriminic acid (19) 
(Bacillus subtilis)   
cLL cytochrome P450 (N-oxide formation and 
aromatization of the DKP-ring) 
  
mycocyclosin (20) 
(Mycobacterium 
          tuberculosis) 
cYY cytochrome P450 (intramolecular C─C 
coupling) 
nocazine E (21)/ 
           neihumicin (22) 
(Nocardiopsis dassonvillei) 
cFY 
       cFF 
CDO (α,β-dehydrogenation) 
methyltransferase (O-methylation) 
bicyclomycin (23) 
(Streptomyces                   
sapporonensis) 
cIL α-KGD (epoxidation) 
three α-KGDs (hydroxylation) 
α-KGD (dehydrogenation) 
cytochrome P450 (hydroxylation)  
dehydrophenylahistin (24) cFH CDO (α,β-dehydrogenation) 
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1.3 Cytochromes P450 
Cytochromes P450 (P450s) constitute a large superfamily of heme-containing 
monooxygenases distributed in all life kingdoms. They catalyze diverse oxidative 
reactions with a wide range of substrates60. The terminology P450 is based on their 
typically maximum absorbance at 450 nm in reduced form when bound to carbon 
monoxide61. P450s are the most versatile biological catalysts in nature for their 
contribution to biosynthesis of steroids, fatty acids, fat-soluble vitamins and bile acids. 
They are also involved in biotransfomation of xenobiotics, metabolism of drugs, as well 
as conversion of alkanes, terpenes and aromatic compounds62. With extraordinarily 
broad substrate spectra and regio- and stereoselectivity, they play important roles in the 
biosynthesis of natural products63,64. 
1.3.1 Catalytic mechanism of P450s 
Since the determination of the first crystal structure of P450cam, a monooxygenase 
metabolizing camphor in Pseudomonas putida, in the mid-1980s65,66, more than 800 
entries with “P450” can be found in the Protein Data Bank (PDB) to date. Many of them 
are involved in natural product biosynthesis67. In all members of P450 family, the only 
absolutely conserved and catalytically most important residue is cysteine (Cys), which is 
situated at the N-terminus of the L-helix and acts as the fifth axial ligand of the heme 
iron coordinating to the Fe atom via a thiolate bond63. The vast majority of P450s 
catalyze the chemical reactions depending on the transfer of electrons to the heme iron 
via an electron transport chain. Based on the components of redox partners, different 
classes of electron transfer chains were described by Hannemann et al.62 Most bacterial 
P450s belong to class I redox system consisting of three separate and soluble proteins, 
i.e. ferredoxin, ferredoxin reductase and P45062. Usually, bacterial P450s, especially 
those from Streptomyces, also accept electrons from heterologous redox partners64. In 
the P450 catalytic cycle, the electrons are transferred from NAD(P)H to iron of the P450, 
resulting in the incorporation of one oxygen atom into the substrate via complex multiple 
steps (Figure 6). The catalytic cycle begins with the binding of substrate to displace the 
iron coordinated water. The ferric heme iron is reduced by the first electron. Molecular 
oxygen binding is followed by the second reduction with electron and two successive 
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protonations of the distal oxygen, leading to the formation of the intermediate 
Compound 0 (Cpd 0, FeIII-OOH) and reactive ferryl-oxo intermediate Compound I (Cpd I, 
FeIV=O, porphyrin π-cation radical). The substrate radical is formed through abstraction 
of one hydrogen atom by Cpd I, and followed by the recombination with hydroxyl radical 
from ferryl-hydroxo Compound II (Cpd II) to give the hydroxylated product. Finally, the 
hydroxylated product is released from the active site and water rebinds to restore the 
enzyme to its resting state. 
 
Figure 6. P450 catalytic cycle with hydroxylation of the substrate RH to ROH as an 
example. 
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1.3.2 Aryl–aryl coupling catalyzed by P450s in natural product biosynthesis 
As ubiquitous catalysts in nature, P450s catalyze diverse reactions in natural product 
biosynthesis. Among them, hydroxylation of C–H or N–H bond and epoxidation of C=C 
bond are regarded as common P450 reactions, leading to only slight changes in the 
substrate skeleton68. These typical P450s often exhibit multifunction and catalyze 
consecutive hydroxylation/epoxidation during the biosynthesis of interesting molecules, 
such as the MycG involved in the formation of macrolide mycinamicin I, II, V from 
Micromonospora griseorubida69,70 and TamI from Streptomyces sp. 307-9 catalyzing the 
production of diverse tirandamycins71,72. In addition to the common P450 reactions, 
unusual reactions, such as aromatic/phenolic coupling, bond cleavage or migration and 
ring opening or rearrangement, have gained more and more attention in recent years. 
One well-known example is the P450 TxtE in the biosynthesis of phytotoxin thaxtomin A 
(10), which catalyzes the unusual nitration of L-tryptophan (25) resulting in the formation 
of L-4-nitrotryptophanthen (26). The P450 enzyme TxtC performs the typical 
phenylalanyl hydroxylation after the CDP assembly (27)25,28,29 (Scheme 2.). Additionally, 
intra-/intermolecular aryl–aryl coupling reactions have been found in many natural 
product biosynthesis, as illustrated in Scheme 3 and Scheme 4, respectively. For 
example, the CDP tailoring P450 CYP121 from Mycobacterium tuberculosis catalyzes 
the intermolecular C–C coupling of the tyrosine side chain of cyclo- L-Tyr-L-Tyr (28) to 
form mycocyclosin (20), which acts as a causative agent of tuberculosis52. In the 
biosynthesis of staurosporine (30) in Streptomyces sp. TP-A0274, two intermediates are 
formed by P450-catalyzed intramolecular C–C and C–N coupling. The indolocarbazole 
skeleton K252c (31) is formed by intramolecular C–C bond connection of 
chromopyrrolic acid (32) by StaP73. StaN catalyzes the C–N bond (C5’-N12) formation 
of the intermediate (33) from holyrine A (34)74. A similar aromatic coupling reaction also 
occurs during the biosynthesis of magnoflorine (35) in the plant Coptis japonica. The 
transformation of (S)-reticuline (36) to (S)-corytuberine (37) is catalyzed by CYP80G275.  
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Scheme 2. Biosynthetic pathway of thaxtomin A. 
 
 
Scheme 3. Examples of intramolecular aryl–aryl coupling reactions catalyzed by P450s. 
The dimeric compounds often show useful and interesting biological activities. One such 
example are the pigments dimeric flaviolins (38 and 39) formed via intermolecular C–C 
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coupling of flaviolin (40) by two P450s (CYP158A1 and CYP158A2) in S. coelicolor A3 
(2). These pigments are thought to protect microbes from UV radiation76,77. Similarly, 
intermolecular dimerization of 1,3,6,8-tetrahydroxynaphthalene (41) to generate 
1,4,6,7,9,12-hexahydroxyperylene-3,10-quinone (42) via intermediate (43) was 
achieved by P-450mel in Streptomyces griseus78. In marine bacteria 
Pseudoalteromonas luteoviolacea 2ta16 and P. phenolica O-BC30, the P450 Bmp7 was 
found to catalyze the formation of polybrominated aromatic compounds (44−46) via 
homo or heterodimerization of their monomers (47, 48)79. In addition to bacteria, P450s 
from fungi also catalyze intermolecular aryl–aryl coupling. Two homologous fungal P450 
enzymes, KtnC from A. niger and DesC from Emericella desertorum, were identified to 
mediate aryl–aryl coupling of 7-demethylsiderin (49) at different positions to form 
regioisomers P-orlandin (50) and M-desertorin A (51), respectively80. In the biosynthesis 
of communesins in Penicillium expansum, the P450 enzyme CnsC is responsible for 
heterodimeric coupling of two different indole moieties, tryptamine (52) and 
aurantioclavine (53), resulting in the formation of heterodimer (54), a precursor of 
communesin scaffold (55)81. The CDP tailoring P450 in the NRPS pathway from A. 
flavus, DtpC, catalyzes the homodimerization of N-methyltryptophenaline (56) to form 
ditryptophenaline (57)34.  The enzymes Bmp7 and CnsC represent rare examples of 
P450s that are able to perform aryl–aryl coupling of two different substrates.  
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Scheme 4. Examples of intermolecular aryl–aryl coupling reactions catalyzed by 
P450s. 
 19
INTRODUCTION 
 
1.3.3 P450s involved in the CDPS pathways 
Although several gene clusters of natural products derived from CDPS pathways have 
been identified (Table 2), only three associated P450s were functionally characterized: 
i) the CYP121 from M. tuberculosis52 described in Scheme 3; ii) CYP134A1 from B. 
subtilis catalyzing double N-oxide formation and aromatization of the DKP-ring of 
cyclo-L-Leu-L-Leu (59) leading to the formation of pulcherriminic acid (19). Further 
transformation to pulcherrimin pigment (60) happens via a non-enzymatic reaction50; iii) 
P450 BcmD, performing the hydroxylation of intermediate 62 in late modification step 
during the biosynthesis of bicyclomycin (23) in Streptomyces sapporonensis, leading 
to the formation of intermediate (63), which is further modified by α-KGD BcmF55. The 
reactions catalyzed by the latter two P450s are illustrated in Scheme 5. 
    
Scheme 5. P450s involved in the CDPS pathways. 
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1.4 Prenylated aromatic compounds in nature 
As mentioned under 1.2.3, prenyltransferases (PTs) participate in many prenylated 
secondary metabolite biosynthesis and catalyze regular (67) or reverse prenylation 
(68) at different positions of the CDP scaffold derived from the NRPS pathway. 
Besides the CDP core, PTs also catalyze the attachment of one or more prenyl 
moieties (69) to other aromatic cores in natural product biosynthesis, such as indole 
(70), tyrosine (71), xanthone (72), flavone (73), and hydroxynaphthalene (74)82-85 
(Figure 7). PTs are found in many living organisms including plants, bacteria, and 
fungi and can be classified in different subgroups based on their amino acid 
sequences structures, and biochemical properties86-88. The resulted prenylated 
products often show biological and pharmacological activities distinct from their non-
prenylated precursors, which makes these enzymes to be attractive biocatalysts for 
structure modifications58,89. 
 
 
Figure 7. Regular and reverse prenyl pattern, different lengths of prenyl moieties 
andaromatic scalfolds as PT acceptors. 
1.4.1 Prenylated tyrosine derivatives 
Tyrosine is one of the 20 proteinogenic amino acids that are used by cells to 
synthesize proteins in nature. It is produced via shikimate pathway in plants and most 
microorganisms and from the essential amino acid phenylalanine (derived from food) 
in mammals90. Benefiting from the para-hydroxyl group, tyrosine is readily to take 
chemical reactions and signal transductions as well as the post-translational 
modifications such as phosphorylation, sulfation, nitration, oxidation, halogenation, 
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glycosylation, AMPylation or cross-linking90. Several simple prenylated tyrosine 
derivatives were found to be O- or C3-prenylated, such as the 5-HT receptor ligand 
(75) isolated from Pithomyces Ellis91, stachyline A (76) found in Stachylidium sp. 
harboring a unique terminal oxime group92 and a C3-prenylated tyrosine (77) isolated 
from Streptomyces sp. IFM 1093793. Until now, two tyrosine PTs have been identified 
and characterized biochemically. The first one, SirD, catalyzes the O-prenylation of L-
tyrosine (78) resulting in 79, which is the precursor of the phytotoxin sirodesmin PL 
(80) in Leptosphaeria maculans94,95. Another tyrosine PT, TyrPT, from an unknown 
biosynthetic pathway in A. niger shows similar biochemical features as SirD (Figure 
8)96. 
 
 
Figure 8. Examples of simple prenylated tyrosine derivatives and the function of the 
two identified tyrosine PTs. 
1.4.2 Chemoenzymatic synthesis of prenylated aromatic compounds with DMAPP 
As described previously, many prenylated secondary metabolites exhibit different and 
efficient activities comparing to their non-prenylated precursors58,97. Therefore, the 
diversity of prenylated compounds has gained increasing attention in pharmaceutical 
study. With the advantage of broad aromatic substrate spectra, high regio- and 
stereoselectivity of the reactions and mild reaction conditions in comparison to the 
chemical synthesis, chemoenzymatic synthesis of unnatural prenylated compounds is of 
interest for current research. Such compounds can be obtained by using aromatic PTs 
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with diverse substrates. For example, the regiospecific regular C4-, C5- and C7-
prenylated simple indole derivatives (81−86 in Figure 9) were generated via 
chemoenzymatic synthesis by the respective L-tryptophan PTs FgaPT2, 5-DMATS and 
7-DMATS in the presence of DMAPP59,98,99. In addition to tryptophan derivatives, the 
indole PTs also use other aromatic substrates with distinct structures such as 
hydroxynaphthalenes, flavonoids, or xanthones100-102. FgaPT2 and 7-DMATS have 
been demonstrated to accept tyrosine and its derivatives as substrates besides the 
simple indole derivatives96,103. Similarly, the tyrosine PTs SirD and TyrPT catalyze both 
the O- or N-prenylation of a variety of tyrosine derivatives and the prenylation of 
tryptophan and derivatives95,96,104,105. 
 
Figure 9. Examples of prenylated indole derivatives. 
 
1.4.3 Chemoenzymatic synthesis of prenylated aromatic compounds with 
unnatural prenyl analogs 
As mentioned above, the PTs of DMATS superfamily utilize a large number of aromatic 
substrates. In contrast to their flexible aromatic substrate spectra, most of the DMATS 
members show a restricted specificity toward their prenyl donors, accepting usually 
DMAPP as prenyl donor88, with a few exceptions that use GPP, or both DMAPP and 
GPP, or DMAPP, GPP, and FPP as prenyl donors102,106-108. To broaden their specificity 
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for alkyl donors, two tryptophan PTs FgaPT2 and 5-DMATS and five cyclic dipeptide 
prenyltransferases BrePT, FtmPT1, AnaPT, CdpNPT, and CdpC3PT have been 
demonstrated prior to this study to accept the unnatural prenyl analogs methylallyl 
diphosphate (MAPP) (87), 2-pentenyl diphosphate (2-pen-PP) (88), and benzyl 
diphosphate (benzyl-PP) (89), with partial or complete shifts of alkylation or benzylation 
positions (90-92) comparing to the natural prenyl donor (Figure 10)109-111.  
 
Figure 10. Examples of unnatural prenyl analogs and alkylated or benzylated L-
tryptophan derivatives. 
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2 Aims of this thesis 
The following issues have been addressed in this thesis: 
1) Identification of CDPSs that catalyze the formation of tryptophan-
containing cyclodipeptides from Streptomyces 
CDPSs catalyze the formation of CDPs by using the loaded tRNAs as substrates. 
Tryptophan-containing CDPs have received an increasing interest in recent years due 
to their promising scaffolds for structural modification. Although over ten specific cWW 
synthases have been functionally characterized, only one CDPS originating from the 
sea anemone Nematostella vectensis was demonstrated to produce several cWXs prior 
to this study. The product yields are however very low with only 0.8–1.0 mg/L in E. coli. 
The aim of this project is to find new CDPSs for the formation of CDPs comprising 
tryptophan and another amino acid. The following experiments were carried out: 
 Search for CDPS homologues in database by blast with the CDPSs that form 
cWW  
 Phylogenetic analysis of the CDPS candidates with the known CDPSs  
 Cloning of the CDPS genes into pET28a vector and expression in E. coli 
 LC-MS analysis of the E. coli cultures harboring the CDPS expressing constructs 
 Isolation and structure elucidation of CDPS products by HR-EIMS and NMR 
analyses 
 Determination of the CDPS product yields on HPLC 
 
2) Functional proof of a cytochrome P450 homologue from 
Streptomyces purpureus NRRL B-5737 
In nature, the CDP cores synthesized by NRPSs or CDPSs are usually further modified 
by diverse tailoring enzymes to form sophisticated compounds. In the first project, 
several CDPSs that catalyze the formation of cWXs have been identified in different 
Streptomyces strains, including cWW synthases from S. pupureus, S. lavendulae, and 
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S. xanthophaeus. In these three strains, the cWW-forming CDPS coding gene is 
genetically associated with a gene encoding putative cytochrome P450 in the 
downstream with the same orientation. The three P450 homologues share sequence 
identities of more than 75% on the amino acid level with each other. Therefore it could 
be speculated that these three clusters might synthesize similar CDP derivatives. The 
aim of this project is to identify the function of the three tailoring P450 homologues by 
taking P450NB5737 as a representative. The following experiments were carried out: 
 Phylogenetic analysis of the three P450 homologues with structurally defined 
natural product P450s from bacteria 
 Phylogenetic analysis of P450s from this study and functionally characterized 
P450s from bacteria 
 Cloning of CDPSNB5737 alone or together with P450NB5737 into integrative plasmid 
pSET152 or replicative vector pPWW50 and expression in S. coelicolor M1146 
 Confirmation of the cWW metabolism by P450NB5737 via biotransformation 
experiment 
 Isolation of the P450NB5737 product and structure elucidation by HR-EIMS and 
NMR analyses 
 Production of the recombinant P450NB5737 in E. coli and performing in vitro assays 
of P450NB5737 
 Postulation of the catalytic mechanism of P450NB5737 
 
3) Biochemical investigations on the acceptance of unnatural DMAPP 
analogs by tyrosine O-prenyltransferases TyrPT and SirD 
Prenyltransferases of the DMATS superfamily show broad substrate spectra, but strict 
prenyl donor specificity. The aim of this thesis was to elucidate the behavior of O-
prenyltransferases TyrPT and SirD towards chemically synthesized DMAPP analogs, 
MAPP, 2-pen-PP and benzyl-PP. The following experiments were carried out:  
 Overproduction of TyrPT and SirD in E. coli and subsequent purification 
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 Incubation of assays containing L-tyrosine and derivatives and the DMAPP 
analogs in the presence of TyrPT and SirD, respectivey 
 Analysis of the enzyme activities on HPLC and isolation of the enzyme products 
 Structure elucidation of the products by HR-EIMS and NMR analyses 
 Determination of the kinetic parameters of the corresponding reactions  
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3 Results and discussion 
3.1 Identification of nine tryptophan-containing cyclcodipeptide 
synthases from Streptomyces strains 
Prior to this study, dozens of CDPSs that are responsible for cyclodipeptide formation 
have been identified37,39-42. Overview the CDPS products, 17 of 20 proteinogenic amino 
acids have been incorporated into cyclodipeptides39. Although over ten specific cWW 
synthases have been characterized39,49,112, CDPSs synthesizing other tryptophan-
containing cyclodipeptides have not been reported for microorganisms.  
The working flow of this project is illustrated in Figure 11. Firstly, to get the CDPSs for 
tryptophan-containing cyclodipeptides, a BlastP search was carried out using 
sequences of known cWW-forming CDPSs. To this end, thirteen candidate CDPSs from 
eleven Streptomyces strains were selected as investigation objectives.  
 
Figure 11. Working flow of identification of cWX-forming CDPSs 
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For functional proof, the coding genes of CDPSs were amplified by PCR with their 
respective gDNA as templates. Subsequently, genes encoding CDPSswere ligated into 
pET28a vector via pGEM T easy constructs and transformed in E. coli SoluBL21. The 
production of CDP was induced with appropriate concentration of IPTG when an 
absorption of OD600 at 0.6 was reached. The expression system was tested with two 
known cWW-forming CDPSs WP_014141671 and WP_014140974 from Streptomyces 
cattleya DSM 46488. The expected product cWW was confirmed by LC-MS and NMR 
analyses. The expression constructs of other eleven CDPSs were also expressed in E. 
coli SoluBL21. The optimized expression condition for each CDPS was tested with 
different IPTG concentrations (0.2 mM and 0.5 mM) and incubation temperatures (20 °C, 
30 °C and 37 °C). The cultures of E. coli transformant harboring each CDPS expression 
construct were analyzed on LC-MS, with the empty vector pET28a as negative control. 
Then CDPSs products were isolated and sent for NMR analysis. Structure elucidation 
revealed nine cWX-forming CDPSs including one cWL, two cWP, and three cWW 
synthases as well as three unspecific CDPSs producing several products with cWA or 
cWY as the major cyclodipeptide (Figure 12). The other two CDPSs WP_031028810 
from Streptomyces sp. NRRL F-5639 and BAU83478 from Streptomyces laurentii DSM 
41684 were proven to catalyze the formation of cFL. 
Total product yields of CDPs were calculated based on HPLC analysis to be 46 to 211 
mg/L E. coli culture after cultivation for 36 h under their optimized conditions. 
Phylogenetic analysis of these CDPS homologues with the known CDPSs from 
actinomycetes revealed that tryptophan-containing cyclodipeptide synthases from 
actinobacteria are located in two clades: clade I comprising only cWX synthases with 
the exception for cLL and clade II including not only cWX synthases but also cFX and 
cYX synthases.  
The results presented in this project expanded significantly the spectrum of tryptophan-
containing cyclodipeptide (93-100) synthases (Scheme 6). And the high product yields 
of cWXs provided a solid basis for further combination of these CDPS genes with other 
modification genes in synthetic biology.  
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Figure 12. HPLC analysis of recombinant E. coli strains with empty vector (a) or with 
CDPS genes (b–l)40. 
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Scheme 6. The CDPSs catalyzing the formation of cWX in this study. 
This project was cooperated with Jing Liu. The expression constructs of CDPSs with 
names “pHY××” (Figure 12 B-G, I, J) were prepared by the author of this thesis. 
 
For details on this work, please see the publication (section 4.1) 
Liu, J.*, Yu, H.*, & Li, S.-M. (2018). Expanding tryptophan-containing cyclodipeptide 
synthase spectrum by identification of nine members from Streptomyces strains. Appl. 
Microbiol. Biotechnol., 102 (10), 4435-4444. [*equal contribution] 
Liu, J*., Yu, H*., & Li, S.-M. (2018). Correction to: Expanding tryptophan-containing 
cyclodipeptide synthase spectrum by identification of nine members from Streptomyces 
strains. Appl. Microbiol. Biotechnol., 102, 5787-5789. [*equal contribution]  
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3.2 Coupling of cyclo-L-Trp-L-Trp and guanine by a P450 homologue 
from Streptomyces purpureus 
Cytochrome P450s are common CDP tailoring enzymes that participate in the 
modification of CDP cores to form sophisticated natural products. However, only three 
P450s involved in CDPS pathways have been identified prior to this study. They are 
CYP121 in the biosynthesis of mycocyclosin from M. tuberculosis52, CYP134A1 in the 
pulcherrimin pathway from B. subtilis50, and the P450 BcmD in the bicyclomycin 
pathway55. Inspection of the CDPS genes identified in the first project revealed that the 
cWW-forming CDPS genes from S. pupureus, S. lavendulae, and S. xanthophaeus are 
respectively associated with a downstream putative cytochrome P450 gene with the 
same orientation (Figure 13). 
 
Figure 13. CDPS- and P450-containing gene clusters from three  
Streptomyces strains. 
 
As is shown in Figure 14, to characterize the three CDP tailoring P450s from S. 
pupureus, S. lavendulae, and S. xanthophaeus, the bioinformatic analysis was made 
firstly. The gene and amino acid sequences of the three P450 homologues were 
downloaded from the NCBI database. Alignments of the three P450 genes with the 
structurally defined P450s from bacteria revealed three featured motifs that are 
conserved in the bacterial P450s: (i) the highly conserved A/G241G242XXT245 motif with 
Thr as a critical residue for the H-bonding network (this residue is replaced by a Ser in 
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the CDP tailoring P450s; EryF numbering); (ii) E280XXR283 motif found in the K helix; (iii) 
G347XXXC351 motif in the heme-binding loop harboring the invariant and catalytically 
most important Cys. Phylogenetic analysis of the CDP tailoring P450s with functionally 
characterized P450s from bacteria indicated that the CDP tailoring P450s of interest are 
closely related to CYP121 as well as P-450mel, CYP158A1 and CYP158A2, which 
catalyze the intramolecular C–C coupling of cYY and dimerization of 
hydroxynaphthalenes/-naphthoquinones via aryl–aryl coupling in Streptomyces76-78. 
 
Figure 14. Working flow of identification of a cWW tailoring P450. 
Due to the high identity of over 75% on the amino acid sequence level among the three 
P450 homologues, the P450NB5737 was investigated as a representative. CDPSNB5737 
alone or together with P450NB5737 were cloned into the integrative plasmid pSET152 or 
replicative vector pPWW50 and expressed in S. coelicolor M1146. LC-MS analysis of 
cultures of M1146 transformants carrying the coexpression constructs of CDPSNB5737 
with P450NB5737 revealed the additional product with [M +H]+ ions at m/z 522.1997 
comparing to the CDPSNB5737 transformant. The cWW metabolism by P450NB5737 was 
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confirmed by feeding 80 μM cWW to two days old culture of CDPSNB5737 transformant. 
For structure elucidation, 13 mg of P450NB5737 product was isolated from 4 L GYM 
cultures of M1146 transformant carrying the expression construct of CDPSNB5737 and 
P450NB5737 and sent to 1H, 13C APT, DQF-COSY, HSQC, and HMBC NMR analyses. 
The structure elucidation indicated that the P450NB5737 catalyze the transfer of a guanine 
moiety to the indole ring of the cWW (102) via a C–N bond, leading to formation of 103 
(Scheme 7).   
 
Scheme 7. Biosynthesis and metabolism of cWW in S. purpureus NRRL B-5737 
(modified from publication113) 
To investigate the activity of P450NB5737 in vitro, the P450NB5737 gene was cloned into 
pET28a vector and expressed in E. coli Rosetta (DE3). P450NB5737 production was 
induced with 0.5 mM IPTG at 18 °C for 20 h in TB media. Approximate 3.5 mg/L culture 
P450NB5737 was obtained after purification with Ni-NTA agarose. SDS-PAGE analysis 
revealed a dominant band at approximate 44.0 kDa (Figure 15). The enzyme assays 
were carried out by using spinach ferredoxin and ferredoxin-NADP+ reductase for 
electron transport. Incubation of the purified P450NB5737 with cWW and guanine in the 
presence of electron transport composition and NADPH resulted in the formation of 
same product as from the CDPSNB5737 and P450NB5737 transformant. No product was 
detected in negative controls with heat-inactivated protein, without cWW or guanine. 
Unfortunately, the conversion yield was extremely low, with only around 1% was 
observed from in vitro assays. Increasing the concentration of ferredoxin, ferredoxin 
reductase, or both to 5-fold did not change the conversion yield. UV-Vis spectra 
analysis of ferrous CO complex of P450NB5737 after reduction with sodium dithionite 
revealed strong absorption at 415 nm of an inactive form and only a very weak shoulder 
peak around 446 nm of the active form. This could be caused by the inappropriate 
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folding or non-incorporation of heme group into P450NB5737 produced in E. coli. The 
incorrect state of the protein could also explain the low activity in vitro.  
 
Figure 15. SDS-PAGE analysis of the recombinant P450NB5737. 
Finally, the catalytic mechanism of P450NB5737 was proposed (Figure 16). In this 
hypothesis, two radicals (compound II) are formed parallel via oxidation of FeII via FeIII 
and ferryl-oxo intermediate (FeIV=O, compound I). Coupling of the two radicals leads to 
the formation of cWW adducts with guanine. 
In conclusion, we identified in this study a P450 enzyme from Streptomyces that 
catalyzes an unusual coupling reaction of a cyclodipeptide with a nucleobase, leading to 
unprecedented adducts of cyclodipeptide with guanine. This represents one additional 
rare atypical P450 example catalyzing the coupling of two different substrates. Coupling 
of guanine with cWW significantly increases the CDP diversity and opens new 
prospective pathways in natural product discovery. To better understand the catalytic 
mechanism of this P450, the crystal structure is necessary to be solved in the future. 
 
1 2
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Figure 16. The proposed catalytic mechanism of P450NB5737. 
 
 
For details on this work, please see the publication (section 4.2) 
Yu, H., Xie, X., & Li, S. M. (2018). Coupling of guanine with cyclo-L-Trp-L-Trp mediated 
by a cytochrome P450 homologue from Streptomyces purpureus. Org. Lett. 20 (16), 
4921-4925. 
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3.3 Tyrosine O-prenyltransferases TyrPT and SirD displaying similar 
behavior toward unnatural alkyl or benzyl diphosphate as their natural 
prenyl donor dimethylallyl diphosphate 
As described previously, prenyltransferases of the DMATS superfamily are versatile 
enzymes accepting a large number of aromatic substrates with relatively strict prenyl 
donor spectra88. To broaden the prenyl donor spectra, the acceptance of the unnatural 
prenyl analogs such as MAPP, 2-pen-PP, and benzyl-PP have been tested in the 
presence of two tryptophan prenyltransferases FgaPT2 and 5-DMATS and five cyclic 
dipeptide prenyltransferases, BrePT, FtmPT1, AnaPT, CdpNPT, and CdpC3PT in our 
laboratory prior to this study109-111. The results indicated that the unnatural DMAPP 
analogs were successfully utilized by these PTs. The structure elucidation of the 
products revealed partial or complete shifts of alkylation or benzylation positions 
comparing to the natural prenyl donor DMAPP109-111. This inspired us to test these 
DMAPP analogues towards tyrosine O-prenyltransferases TyrPT and SirD. The working 
flow was described in Figure 17. 
 
Figure 17. Working flow of investigation on the acceptance of TyrPT and SirD toward 
unnatural DMAPP analogs. 
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The enzyme assays towards the unnatural substrates often require relatively high 
amount of proteins in comparison to their natural substrates. Therefore the expression 
vector of SirD was changed from pQE70 (pAK2) to pET28a (pHY07). With the help of 
the strong T7 promoter and nutrient-rich TB media, the protein yield was improved from 
2 to 4 mg/L E. coli SoluBL21 culture. TyrPT (pHC 16) with yield of 4–6 mg/L was 
obtained in E. coli SoluBL21.  
At first, the DMAPP analogs MAPP, 2-pen-PP and benzyl-PP were incubated in the 
presence of TyrPT or SirD together with tyrosine and 12 derivatives. The conversion 
yields were measured on HPLC. Nineteen of the enzyme assays showed product yields 
of more than 10%. Only one substrate, 4-amino-L-phenylalanine (106), accepted all 
three DMAPP analogs with high conversions (34%–67%) for both TyrPT and SirD.  
For structure elucidation, nine of the products were isolated on HPLC using reverse 
phase C18 column and subjected to NMR and MS analyses. It was shown that both 
TyrPT and SirD catalyzed the O-/N-alkylation/benzylation of tyrosine and derivatives 
(104-117) at the same position as in the presence of their natural prenyl donor DMAPP 
(Scheme 8). 
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Scheme 8. The reactions of tyrosine and derivatives and unnatural DMAPP analogs 
catalyzed by TyrPT and SirD, respectively. 
 
Finally, Michaelis-Menten constants (KM) values and turnover number (kcat) of TyrPT 
and SirD were calculated for unnatural alkyl or benzyl donors in the presence of L-
tyrosine or 4-amino- L-phenylalanine. The results indicated that MAPP was accepted by 
both enzymes with lower KM values than those of 2-pen-PP, benzyl-PP, and DMAPP. 
All three unnatural donors showed much lower kcat values than those of DMAPP.  
In conclusion, tyrosine O-prenyltransferases TyrPT and SirD were demonstrated to 
accept MAPP, 2-pen-PP and benzyl-PP in the presence of tyrosine and derivatives by 
exhibiting similar behavior as their natural prenyl donor DMAPP. This study expanded 
the prenyl donor spectra of TyrPT and SirD and increased significantly the diversity of 
prenylated products by chemoenzymatic synthesis. 
 
For details on this work, please see the publication (section 4.3) 
Yu, H., Liebhold, M., Xie, X., & Li, S. M. (2015). Tyrosine O-prenyltransferases TyrPT 
and SirD displaying similar behavior toward unnatural alkyl or benzyl diphosphate as 
their natural prenyl donor dimethylallyl diphosphate. Appl. Microbiol. Biotechnol., 99 (17), 
7115-7124. 
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Abstract
Cyclodipeptide synthases (CDPSs) comprise normally 200–300 amino acid residues and are mainly found in bacteria. They
hijack aminoacyl-tRNAs from the ribosomal machinery for cyclodipeptide formation. In this study, nine new CDPS genes from
eight Streptomyces strains were cloned into pET28a vector and expressed in Escherichia coli. Structural elucidation of the
isolated products led to the identification of one cyclo-L-Trp-L-Leu, two cyclo-L-Trp-L-Pro, and three cyclo-L-Trp-L-Trp
synthases. Other three CDPSs produce cyclo-L-Trp-L-Ala or cyclo-L-Trp-L-Tyr as the major cyclodipeptide. Total product yields
of 46 to 211 mg/L E. coli culture were obtained. Our findings represent rare examples of CDPS family derived from
actinobacteria that form various tryptophan-containing cyclodipeptides. Furthermore, this study highlights the potential of the
microbial machinery for tryptophan-containing cyclodipeptide biosynthesis and provides valid experimental basis for further
combination of these CDPS genes with other modification genes in synthetic biology.
Keywords Aminoacyl t-RNA . Diketopiperazine . Cyclodipeptide synthase . Streptomyces . Tryptophan-containing
cyclodipeptide
Introduction
Cyclodipeptides (CDPs) with a 2,5-diketopiperazine (DKP)
skeleton are chemically condensation products of two amino
acids and represent a class of secondary metabolites with sim-
ple scaffold, but different modification possibilities
(Borthwick 2012). A large number of DKP derivatives show
a broad range of biological and pharmacological activities
such as antibacterial, antifungal, antiviral, and immunosup-
pressive activities (Borthwick 2012; Giessen et al. 2013),
which make them attractive molecules for drug discovery
and development. So far, DKP derivatives are mainly isolated
from microorganism including bacteria and fungi. The DKP
scaffold in fungi is usually assembled by bimodular
nonribosomal peptide synthetases (NRPSs) with a typical
polypeptide chain length of 2300 amino acids (Maiya et al.
2006;Walsh 2016; Xu et al. 2014), whereas in bacteria mainly
by tRNA-dependent cyclodipeptide synthases (CDPSs) com-
prising normally 200–300 amino acid residues (Giessen and
Marahiel 2014; Gondry et al. 2009; James et al. 2015;
Moutiez et al. 2017). NRPSs can use both proteinogenic and
non-proteinogenic free amino acids as substrates, while
CDPSs directly hijack the activated aminoacyl-tRNAs (aa-
tRNAs) from the ribosomal machinery for cyclodipeptide for-
mation (Huang et al. 2010).
The DKP scaffold is frequently modified by methylation,
hydroxylation, prenylation, dimerization, and further cycliza-
tion (Borthwick 2012; Giessen et al. 2013; Li 2010; Xu et al.
2014). Among the DKPs, tryptophan-containing CDPs have
received an increasing interest in recent years due to their
promising scaffolds for structural modification (Li 2010; Xu
et al. 2014). The electron-rich indole ring in tryptophanyl
moiety can undergo different enzymatic and spontaneous
modifications and rearrangement like prenylation, oxidation,
methylation, and dehydrogenation to generate increased
chemical complexity (Alkhalaf and Ryan 2015; Walsh 2014).
Since 2005, we have intensively studied prenyltranferases
(PTs) involved in the biosynthesis of indole alkaloids in mi-
croorganisms, especially those for the prenylation of
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tryptophan and tryptophan-containing CDPs (Winkelblech
et al. 2015). The tryptophan-containing CDP PTs catalyzed
regio- and stereospecific prenylations at the indole ring. PTs
for specific prenylation at nearly all the positions of the indole
ring have been characterized (Winkelblech et al. 2015;
Wohlgemuth et al. 2017). Most of these PTs are from ascomy-
cetous fungi and are involved in the modification of CDPs
assembled by NRPSs. In the view of synthetic biology, it
would be of essential importance to combine such PT genes
with the small CDPS genes forming tryptophan-containing
CDPs, especially those for cyclo-L-Trp-L-Pro (cWP), cyclo-
L-Trp-L-Ala (cWA), cyclo-L-Trp-L-Leu (cWL), and cyclo-L-
Trp-L-Trp (cWW). All these CDPs serve as precursors in the
biosynthesis of diverse pharmacologically active compounds
and are very well accepted by microbial PTs (Fan et al. 2015;
Li 2010; Winkelblech et al. 2015).
By the end of July 2016, about 450 putative CDPS genes
were identified by sequence homology search and their num-
ber is increasing steadily (Moutiez et al. 2017). Sixty-five of
these genes have been proven to be responsible for the forma-
tion of different DKPs and about 30 are from actinomycetes
(Brockmeyer and Li 2017; Jacques et al. 2015; James et al.
2015; Moutiez et al. 2017). At least ten of the identified
CDPSs from eight actinomycetes catalyze the formation of
cWW as the sole product (Fig. S1). These include
Amir_4627 from Actinosynnema mirum, NozA, and NcdA
from Nocardiopsis sp. CMB-M0232, whose products had
been isolated and identified (Giessen et al. 2013; James et al.
2015). The products of other known cWW synthases were
identified by LC-MS analysis (Jacques et al. 2015). CDPSs
synthesizing other tryptophan-containing cyclodipeptides
have not been reported in microorganisms. Until now, only
one CDPS originating from the sea anemone Nematostella
vectensis was demonstrated to produce a number of
tryptophan-containing cyclodipeptides like cWL, cWA, cyclo-
L-Trp-L-Phe (cWF), cyclo-L-Trp-L-Met (cWM), and cyclo-L-
Trp-Gly (cWG) with very low product yields of 0.8–1.0 mg/L
in Escherichia coli (Seguin et al. 2011). It is therefore abso-
lutely essential to find new CDPSs for the formation of DKPs
comprising tryptophan and another amino acid.
Materials and methods
Computer-assisted sequence analysis
Protein sequences listed in Figs. 1 and S1 were taken from the
NCBI database (http://www.ncbi.nlm.nih.gov/protein) and
compared with each other by using BLAST programs (http://
blast.ncbi.nlm.nih.gov/). Multiple sequence alignments were
carried out by using the program ClustalW and visualized
with ESPript 3.0 (http://espript.ibcp.fr/ESPript/cgi-bin/
ESPript.cgi) to identify strictly conserved amino acid residues.
The phylogenetic trees in Figs. 1 and S1 were created by
MEGA version 5.0 (http://www.megasoftware.net).
Bacterial strains, plasmids, and culture conditions
pGEM-T Easy used for cloning and pET28a (+) for expres-
sion experiments were obtained from Promega (Mannheim,
Germany) and Novagen (Darmstadt, Germany), respectively.
E. coli DH5α (Invitrogen) was used as host for cloning and
SoluBL21 (Genlantis) for expression experiments. They were
grown at 37 °C in liquid Luria-Bertani (LB) medium (10 g/L
tryptone, 5 g/L yeast extract, and 5 g/L NaCl)) or on solid LB
medium with 1.5% agar (w/v). For selection of recombinant
E. coli strains, 100 μg/mL of ampicillin or 50 μg/mL of kana-
mycin were supplied in the media.
Streptomyces strains listed in Table S1 were kindly provid-
ed by ARS Culture Collection (NRRL) or purchased from
Deutsche Sammlung von Mikroorganismen und Zellkulturen
GmbH (DSMZ). They were maintained at 28 °C in GYM
(4.0 g/L glucose, 4.0 g/L yeast extract, 10.0 g/L malt extract,
15.0 g/L agar, and pH 7.2) or ISP4 medium (10.0 g/L soluble
starch, 1.0 g/L K2HPO4, 1.0 g/L MgSO4 7H2O, 1.0 g/L NaCl,
2.0 g/L (NH4)2SO4, 1.0 g/L CaCO3, 1.0 mL/L trace element
solution, 15.0 g/L agar, and pH 7.2).
Plasmid construction and gene expression in E. coli
Genetic manipulation in E. coli was carried out according to
the protocol by Sambrook and Russell (2001). Isolation of
genomic DNA from Streptomyceswas performed as described
previously (Kieser et al. 2000). The genes encoding CDPSs
were amplified by PCR from genomic DNA by using primers
listed in Table 1 with Phusion® High-Fidelity DNA
Polymerase from New England Biolabs (NEB). The generat-
ed PCR fragments were cloned into pGEM-T Easy vector and
sequenced by SEQLAB (Göttingen, Germany) to confirm se-
quence integrity. After sequencing, the fragments were re-
leased with the appropriate restriction endonucleases from
pGEM-T Easy vector and ligated into pET28a (+) vector,
which was digested with the same enzymes previously. The
generated plasmids (Table 1) were transformed into E. coli
SoluBL21 for gene expression.
For CDPS overproduction, 0.5 mL of 16-h cultures of dif-
ferent expression constructs was used to inoculate 50 mL LB
medium containing 50 μg/mL kanamycin. The cultures were
maintained at 230 rpm and 37 °C to an absorption at 600 nm
of about 0.6. Isopropyl β-D-thiogalactopyranoside (IPTG)
was then added to the cultures to a final concentration of 0.2
or 0.5 mM. The induction was kept at 20, 30, or 37 °C for 20 h
for condition optimization (Table S2) or for 36 h for quantifi-
cation. One milliliter of culture was extracted with one volume
of ethyl acetate for three times. The organic phases were com-
bined and evaporated, and the residues were afterward
4436 Appl Microbiol Biotechnol (2018) 102:4435–4444
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dissolved in 40 μL of methanol. Five microliters of such sam-
ples were taken for LC-MS analysis.
HPLC and LC-MS analyses
The ethyl acetate extracts were analyzed on an Agilent HPLC
1260 series equipped with a photo diode array detector and a
Bruker microTOF QIII mass spectrometer by using the
Agilent Eclipse XDB C18 column (5 μm, 4.6 × 150 mm). A
linear gradient of 5–100% acetonitrile in water, both contain-
ing 0.1% formic acid, in 40 min and a flow rate at 0.25 mL/
min were used. The column was then washed with 100%
acetonitrile containing 0.1% formic acid for 5 min and equil-
ibrated with 5% acetonitrile in water for 5 min. The parame-
ters of the spectrometer were set as following: electrospray
positive ion mode for ionization, capillary voltage with
4.5 kV, collision energy with 8.0 eV.
For quantification, an Agilent HPLC 1200 series equipped
with a photo diode array detector and an identical column
were used. A linear gradient of 10 to 100% acetonitrile in
water without acid in 40 min was followed by 100% acetoni-
trile for 5 min and 10% acetonitrile in water for 5 min. The
flow rate was 0.5 mL/min. The absorption at 280 nmwas used
for quantification.
Fig. 1 Phylogenetic analysis of CDPSs from actinobacteria. The main CDPS products are given in parenthesis. Enzymes investigated in this study are
highlighted in red
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Isolation and structural elucidation of generated
cyclodipeptides
For structural elucidation of the accumulated CDPs, E. coli
SoluBL21 cultures carrying the respective expression con-
structs were prepared under the best tested conditions
(Table S2) and extracted with ethyl acetate. The CDPs were
then isolated on an Agilent HPLC 1260 series equipped with a
photo diode array detector by using a semi-preparative
Multospher 120 RP-18 column (10 × 250 mm, 5 μm) with
the same solvents and gradient as for quantification. The flow
rate was set to 2.5 mL/min. The obtained products were puri-
fied on the same column with slightly improved gradients, if
necessary. In this study, 5, 3, and 4 mg of cWW were isolated
as white powders from 300 mL E. coli cultures with pHY34,
pHY11, and pHY09, respectively. Thirty milligrams of cWP
and 12 mg of cWL were isolated as white powders from
1000 mL E. coli/pHY107 and E. coli/pJL26, respectively.
From 2000 mL E. coli culture with pJL25, 1.5 mg of cWA,
10 mg of cyclo-L-Trp-L-Tyr (cWY), 5 mg of cWM, 2.5 mg of
cyclo-L-Trp-L-Val (cWV), and 2.5 mg of cWF were obtained
as white powders.
The isolated compounds were subjected to NMR and
MS analyses. 1H NMR spectra (Figs. S2−S9) were record-
ed at room temperature on an ECX-500 spectrometer
(JEOL, Tokyo, Japan). All spectra were processed with
MestReNova 5.2.2 (Metrelab Research, S5 Santiago de
Compostel la , Spain). MS and NMR data of the
cyclodipeptides are provided as Tables S3 and S4.
Interpretation of the NMR and MS data of the isolated
products and comparison with those of known compounds
led to the undoubted identification of the cyclodipeptides.
Results
Phylogenetic analysis of CDPSs
Phylogenetic analysis of known CDPSs from actinomy-
cetes (Fig. S1) revealed that the known cWW synthases
are located close together, with the exception for
WP_016576960 from Streptomyces albulus. CDPSs for
DKPs consisting of aliphatic amino acids like cyclo-L-
Cys-L-Cys (cCC) and cyclo-L-Glu-L-Ala (cEA) and those
Table 1 Information on CDPSs identified in this study
CDPS Accession
number
Protein
length (aa)
Primer sequences (5′-3′) Cloning constructs
in pGEM-T easy
Cloning sites
in pET28a
Expression
constructs
CWWS1D46488 WP_014141671 278 AACATATGCACGACAACGGTCATCGGCCC pHY02 NdeI pHY34
TTGGATCCTTACGTCACCGGCT BamHI
CWWS2D46488 WP_014140974 234 GCCATATGCTGCATCGAACGTCCTT pHY01 NdeI pHY11
TAGGATCCTCACGGCTCGGCGGGCAGTT BamHI
CWWS1NB2774 WP_078950527 265 CATATGACGATCACAGCTGACGCATCATTC pHY72 NdeI pHY82
GGATCCTCAAGCTGCTCGACGCTCAT BamHI
CWWS1NB5737 WP_019889609 239 GCCATATGACTCTCATCGAAGACAC pHY08 NdeI pHY09
GGATCCTCAAGCGGCTCGACGGTCAT BamHI
CWWS1NB5414 WP_063768158 273 CATATGAGGGCGATCACACAGGTGAC pHY77 NdeI pHY83
GGATCCTCAAGCTGCTCGACGCTCAT BamHI
CWPS1NS1868 WP_078873129 241 CATATGAACACTTCCCTCGCTGC pHY103 NdeI pHY107
GAATTCTCAGCGTTCGGCCGCCCGGTC EcoRI
CWLS1NF5053 WP_051847149 243 CATATGTGCGAGGGCGCCGATGTGC pJL03 NdeI pJL26
a
GGATCCTCAGGATTCGTCCACCGG BamHI
CWPS1NF5123 WP_052397358 263 CATATGACCAGCAGGACCGAAAC pHY100 NdeI pHY105
GAATTCTCACGGAAGCAGCCGGGGG EcoRI
CWXS1NS1868 WP_078872750 267 CATATGGCCACACACGCCTCCGC pHY101 NdeI pHY106
GAATTCTCACTGCTGCGTCACGTGGTC EcoRI
CWXS1NB3589 KOG90878 255 CATATGGGGGCCCCGCAGCCC pJL02 NdeI pJL25
GGATCCTCACGTCAAGTCCCTTTCTCC BamHI
CWXS1NB24309 WP_078624487 282 GCGCATATGAGTGCATCGCAGGCTGCTG pJL01 NdeI pJL24
b
GGATCCTCACGTCACGTCCCCTGC BamHI
CPYS1NF5639 WP_031028810 278 CATATGAACCGCCGCTGTTCCTTCG pJL04 NdeI pJL29
GGATCCTCATGCTCCTGGGGCACTG BamHI
CPYS1D41684 BAU83478 224 CGCATATGAACCAGTTCGACGTGCTGCC pJL05 NdeI pJL30
c
GGATCCCCGGACCACGAGGAAGCC BamHI
Restriction sites for cloning are underlined in primer sequences
a The 12 base pairs at the 5′-end of the sequence coding for WP_051847149 were not included in the expression construct pJL26
b The 96 base pairs at the 5′-end of the sequence coding for WP_078624487 were not included in the expression construct pJL24
cAccording to the annotation in database, BAU83478 comprises 484 amino acids and consists of CDPS sequence at its N-terminus and that for a putative
methyltransferase at its C-terminus. The sequence coding for amino acids 1-224 of BAU83478 was cloned into pET28a generating pJL30
4438 Appl Microbiol Biotechnol (2018) 102:4435–4444
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comprising aromatic amino acids such as cyclo-L-Tyr-L-
Tyr (cYY) and cyclo-L-Tyr-L-X (cYX) build their own
groups. To get CDPSs for other tryptophan-containing
DKPs rather than cWW, we searched in databases for
homologs of the actinobacterial cWW synthases and inte-
grated them into Fig. S1 generating Fig. 1. Thirteen can-
didate CDPSs close to cWW and cYY synthases from 11
Streptomyces strains (highlighted in red in Fig. 1) were
selected as investigation objectives.
Overproduction of CDPSs in E. coli and identification
of the products
For functional proof, we established our expression system in
E. coli SoluBL21 by using the two known CDPSs
WP_014141671 and WP_014140974 from Streptomyces
cattleya DSM 46488, termed CWWS1D46488 (cWW synthase
1 from strain DSM 46488) and CWWS2D46488 in this study,
respectively (Fig. 1). After optimization of expression condi-
tions (Table S2), the 20-h-old cultures after induction at 30 °C
with 0.5 mM IPTG for CWWS1D46488 and 0.2 mM for
CWWS2D46488 were extracted with ethyl acetate and then
analyzed on LC-MS. In comparison to the culture of E. coli
harboring the empty vector (Fig. 2a), one additional predom-
inant peak each with the expected [M + H]+ ion at m/z
373.1636 for cWW was detected in E. coli transformants
(Fig. 2b, c). Isolation and structure elucidation of both peaks
with the help of NMR confirmed their integrity as cWW
(Tables S3 and S4, Fig. S2).
In analogy, the other nine candidate genes were individu-
ally cloned into pET28a (+) (Table 1) and expressed in E. coli
SoluBL21 under different optimized conditions (Table S2).
The ethyl acetate extracts of the 20-h cultures were analyzed
on LC-MS. In comparison to that of negative control (Fig. 2a),
Fig. 2 LC-MS analysis of
recombinant E. coli strains with
empty vector (a) or with CDPSs
(b–l). The ethyl acetate extracts
were analyzed on an Agilent
HPLC series 1260 with UVand
mass detections. Absorptions at
280 nm are illustrated in this
figure. The products are predicted
by inspection of their exact [M +
H]+ ions and proven by NMR
analysis after isolation
Appl Microbiol Biotechnol (2018) 102:4435–4444 4439
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the chromatograms of five CDPS transformants showed one
predominant product peak each (Fig. 2d–h). These include
WP_078950527 from Streptomyces lavendulae NRRL B-
2774 (Fig. 2d),WP_019889609 from Streptomyces purpureus
NRRL B-5737 (Fig. 2e), WP_063768158 from Streptomyces
xanthophaeus NRRL B-5414 (Fig. 2f), WP_078873129 from
Strep tomyces sp . NRRL S-1868 (F ig . 2g) , and
WP_051847149 from Streptomyces sp. NRRL F-5053 (Fig.
2h). The products of the first three transformants (Fig. 2d–f)
share the same retention time and [M+H]+ ion with those of
the two known CWWS1D46488 and CWWS2D46488 (Fig. 2b,
c), indicating the presence of cWW. Interpretation of the NMR
andMS data of the isolated peak from the culture with pHY09
(Tables S3 and S4, Fig. S2) confirmed these products to be
cWW (Giessen et al. 2013; Lu et al. 2017). Therefore, these
three enzymes were termed CWWS1NB2774, CWWS1NB5737,
and CWWS1NB5414, respectively (Fig. 3).
For structure elucidation, the products of WP_078873129
(Fig. 2g) andWP_051847149 (Fig. 2h) were isolated from the
bacterial cultures and subjected to NMR and MS analyses
(Tables S3 and S4; Figs. S3 and S4), which proved unequiv-
ocally cWP (Grundmann and Li 2005; He et al. 2013; Kumar
et al. 2014) as the sole product of WP_078873129, termed
hereafter CWPS1NS1868 (Fig. 3). The two products of
WP_051847149 with a ratio of 120:1 were identified as
cWL (Kumar et al. 2014) and cWF (Chu et al. 2011),
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respectively. Due to the significant dominance of cWL, this
enzyme was named as CWLS1NF5053 (Fig. 3).
Two product peaks each were detected in the transformants
withWP_052397358 from Streptomyces sp. NRRLF-5123 (Fig.
2i) and another CDPS WP_078872750 from Streptomyces sp.
NRRL S-1868 (Fig. 2j). One of them was found in both extracts
and identified as cWP by comparison of its retention time and
[M +H]+ ion with those of CWPS1NS1868 product (Fig. 2g).
cWP in the transformant withWP_052397358 contributes about
94% to the total CDPs, and this enzyme was therefore termed
CWPS1NF5123. The minor product of CWPS1NF5123 showed a
[M+H]+ of cWL.Another main product inE. coliwith pHY106
(Fig. 2j) had a [M+H]+ of cWA, which was identified by com-
parison with the product from KOG90878 of Streptomyces
varsoviensis NRRL B-3589 (Fig. 2k). WP_078872750 was
therefore termed CWXS1NS1868.
The transformant with KOG90878 had a similar and
complex product spectrum as WP_078624487 from
Streptomyces monomycini NRRL B-24309 (Fig. 2l).
Two predominant and at least four minor peaks were de-
tected for both cultures at 280 nm. They differ slightly
from each other in the product yields and ratios, especial-
ly those of the two dominant peaks. Product isolation
from the culture with KOG90878 and structural elucida-
tion proved the main peak at 15.4 min to be cWY and the
second major peak as a mixture of cWF and cWW. The
four minor peaks were identified as cWA, cWM, cWV,
and cWL, respectively (Tables S3 and S4; Figs. S5−S9).
KOG90878 and WP_078624487 are therefore responsi-
ble for the formation of at least seven tryptophan-
containing cyclodipeptides and termed CWXS1NB3589
and CWXS1NB24309, respectively (Fig. 3).
Product yields of CDPs
Generally, high product yield is a prerequisite for poten-
tial application in the biotechnology. The product yields
of cWW from E. coli culture at 29 and 42 mg/L were
reported for the known cWW synthases Amir_4627 and
NozA after codon optimization, respectively (Giessen
et al. 2013; James et al. 2015). To prove the productivity
of the recombinant strains, we determined the CDP con-
tents of 36-h-old cultures by HPLC analysis using the
isolated products as standards. As shown in Fig. 4, the
product yields achieved in this study for several enzymes
are much higher than those mentioned above. The product
yields of the five cWW synthases were detected between
46 ± 10 and 104 ± 10 mg/L with the best one for
CWWS1NB2774. The highest product yield of 211 ±
12 mg cWP per liter culture was observed for the culture
with CWPS1NS1868, followed by 120 ± 5 mg cWL in the
culture with CWLS1NF5053. Total product yields between
100 and 140 mg/L were calculated for other four CDPSs.
These data provide a solid basis for further combination
of these CDPS genes with other modification genes in
synthetic biology.
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cW WFig. 4 Product yields of CDPSs.
The data were obtained from three
independent 36-h old cultures
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Discussion
To find candidates for the formation of tryptophan-containing
CDPs, we searched the database by using known cWW
synthases as probes and carried out phylogenetic analysis.
Gene expression and identification of CDP products led to
identification of nine new members for the biosynthesis of
tryptophan-containing CDPs. Inspection the phylogenetic tree
(Fig. 1) revealed that the tryptophan-containing
cyclodipeptide synthases from actinobacteria are located in
two clades. With the exception for cyclo-L-Leu-L-Leu (cLL),
the clade I comprises only cWX synthases, while the members
of clade II are responsible for the formation of not only cWX,
but also cYX and cFX. To prove the diversity of cWX clade II,
we took two genes close to cYX synthases from this clade and
expressed them in E. coli. As shown in Fig. S10,
WP_031028810 from Streptomyces sp. NRRL F-5639 and
BAU83478 from Streptomyces laurentii DSM 41684 were
proven to be responsible for the formation of cyclo-L-Pro-L-
Tyr (cPY). Together with the CDPSs for tryptophan-
containing cyclodipeptide biosynthesis (Figs. 2, 3, and 4),
these results provide evidence that phylogenetic analysis
could be successfully used for prediction and finding of de-
sired CDPS candidates. However, exact CDPS product cannot
be predicted by just phylogenetic analysis. For example, the
13 specific cWW synthases are distributed in two cWX
clades. One of the cWP synthases, CWPS1NF5123 is closer to
CWWS1D46488 than to the second one CWPS1NS1868, which
is again closer to CWXS1NS1868. CWPS1NS1868 and
CWXS1NS1868 share a sequence identity of 62% on the amino
acid level, and the latter produces a mixture of cWP and cWA
with a ratio of 15:7 (Figs. 2 and 4).
Based on crystal structure and mutagenesis experiments,
Moutiez et al. proposed that two pockets of CDPSs are for
aminoacyl-tRNA binding (Jacques et al. 2015; Moutiez et al.
2014a; Moutiez et al. 2014b). It was postulated that P1 is more
Table 2 Amino acid residues of selected CDPSs constituting the two binding pockets
Amino acids constituting
binding pocket P1
Amino acids constituting
binding pocket P2
Reported
product
Predicted
product*
Identified in
this study
AlbC L33 G35 V65 V67 L119 L185 F186 L200 M152 A155 V156 N159 I204 T206 P207 cFL, cFF, cFY
Amir_4627 V33 G35 V65 P67 M119 F184 F185 N199 M152 E155 V156 L159 R203 L205 P206 cWW (Giessen
et al. 2013)
NozA L32 G34 V64 A66 L118 F183 F184 S198 M151 A154 V155 S158 M202 L204 P205 cWW (James
et al. 2015)
NcdA V36 G38 V58 P60 M112 F177 F178 N192 M145 D148 V149 A152 R196 L198 P199 cWW (James
et al. 2015)
WP_016576960 L53 G55 I85 P87 L139 L204 C205 H219 A17 K175 A176 S179 Q223 I225 P226 cWW (Jacques
et al. 2015)
WP_009073312 V26 G28 I58 P60 M112 F177 F178 N192 M145 E148 V149 A152 Q196 L198 P197 cWW (Jacques
et al. 2015)
EPD89497 V29 G31 I61 P63 M115 F180 F181 C195 A148 T151 V152 A155 R199 L201 P198 cWW (Jacques
et al. 2015)
WP_027751606 V25 G27 I57 P59 M111 F176 F177 N191 M144 D147 V148 A151 Q195 L197 P208 cWW (Jacques
et al. 2015)
WP_017537615 V35 G37 I67 P69 M121 F186 F187 N201 M154 E157 V159 A171 R205 L207 P197 cWW (Jacques
et al. 2015)
CWWS1D46488 V77 G79 V109 P111 L164 F229 F230 C242 M197 A200 A201 S204 K246 V248 P249 cWW (Jacques
et al. 2015)
cWW
CWWS2D46488 V27 G29 V59 P61 M113 F178 F179 C193 M146 E149 A150 A153 R197 I199 P200 cWW (Jacques
et al. 2015)
cWW
CWWS1NB2774 L29 G31 V61 A63 L115 F181 F182 A196 M148 H151 F152 S155 V200 M202 P203 cFX cWW
CWWS1NB5737 L28 G30 V60 A62 L114 F180 F181 S195 M147 T150 F151 P154 Q199 I201 P202 cFX cWW
CWWS1NB5414 L35 G37 V67 A69 L121 F187 F188 A200 M154 H157 F158 S161 V204 M206 P207 cFX cWW
CWPS1NS1868 L32 G34 I64 P66 L118 F189 F190 V204 A151 R154 A155 V158 M208 V210 P211 cFX cWP
CWLS1NF5053 L36 G38 V68 A70 L122 F188 L189 S203 M155 S158 F159 G162 M207 A209 Q210 cFX cWL
CWPS1NF5123 L42 G44 V74 P76 L128 L193 L194 A208 A161 S164 V165 G168 K212 I214 D215 cFX cWP
CWXS1NS1868 L43 G45 I75 P77 L129 F205 F206 A220 L162 R165 A166 V169 A224 V226 G227 cFX cWA, cWP
CWXS1NB3589 L30 G32 I62 A64 L116 F193 F194 S208 M149 R152 H153 G156 M212 T214 P215 cFX cWY, cWF,
cWW
CWXS1NB24309 – – I30 A32 L84 F177 F178 S192 M117 I120 H121 G124 L196 T198 P199 cFX cWY, cWF,
cWW
*The products of the CDPSs of interest were predicted in a previous report (in bold) (Jacques et al. 2015) and in this study (in italic) according to the
conserved residues suggested by Jacques et al. (Jacques et al. 2015)
4442 Appl Microbiol Biotechnol (2018) 102:4435–4444
 48
specific for binding the first aminoacyl-tRNA, and the wider
pocket P2 is responsible for the less specific binding of the
second and often variable aminoacyl-tRNA (Moutiez et al.
2014a; Moutiez et al. 2014b). The amino acid residues of the
two pockets were used for prediction of CDPS products
(Jacques et al. 2015). With the help of the residues in the two
pockets, the functions of the nine tryptophan-containing CDPSs
identified in this study were predicted to be responsible for the
formation of cFX (Table 2) (Jacques et al. 2015). However, as
shown in Figs. 2, 3, and 4, only CWLS1NF5053, CWXS1NB3589,
and CWXS1NB24309 produce cWF as minor or second major
product, with 1, 11, and 22% of total CDPs, respectively. No
cFXwas detected in other CDPS transformants. Comparing the
amino acid residues in pockets 1 and 2 of tryptophan-
containing cyclodipeptide synthases with each other and with
those of cyclo-L-Phe-L-Leu (cFL) synthase AlbC (Table 2) re-
vealed no clear indications for cWX synthases. In a previous
study, we demonstrated that mutation of the related residues in
the pocket P1 did not lead to the desired changes of product
spectrum, but their product yields (Brockmeyer and Li 2017).
This indicates that these prediction tools still need to be opti-
mized by identification of more CDPS structures and amino
acid residues in the binding pockets.
In summary, after confirmation of two known cWW
synthases, we identified three new cWW, one cWL, and two
cWP synthases from Streptomyces, which catalyze the forma-
tion of one predominant DKP. Three additional CDPSs pro-
duce one DKP like cWA or cWY as the major metabolite
(Figs. 2 and 4). These CDPSs are thus ideal candidates for
production of tryptophan-containing CDPs for further modi-
fication by tailoring enzymes like PTs. It should be also men-
tioned that cWV was not reported as CDPS product prior to
this study. Therefore, our results expand significantly the
product spectrum of tryptophan-containing cyclodipeptide
synthases and raise hopes to find other members of this im-
portant enzyme group.
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Fig. 1 Phylogenetic analysis of CDPSs from actinobacteria. The main CDPS products are given in parenthesis. Enzymes investigated in this study are
highlighted in red
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Table 1 Information on CDPSs identified in this study
CDPS Accession
number
Protein
length (aa)
Primer sequences (5’-3’) Cloning constructs
in pGEM-T easy
Cloning sites
in pET28a
Expression
constructs
CWWS1D46488 WP_014141671 278 AACATATGCACGACAACGGTCATCGGCCC
TTGGATCCTTACGTCACCGGCT
pHY02 NdeI
BamHI
pHY34
CWWS2D46488 WP_014140974 234 GCCATATGCTGCATCGAACGTCCTT
TAGGATCCTCACGGCTCGGCGGGCAGTT
pHY01 NdeI
BamHI
pHY11
CWWS1NB2774 WP_078950527 265 CATATGACGATCACAGCTGACGCATCATTC
GGATCCTCAAGCTGCTCGACGCTCAT
pHY72 NdeI
BamHI
pHY82
CWWS1NB5737 WP_019889609 239 GCCATATGACTCTCATCGAAGACAC
GGATCCTCAAGCGGCTCGACGGTCAT
pHY08 NdeI
BamHI
pHY09
CWWS1NB5414 WP_063768158 273 CATATGAGGGCGATCACACAGGTGAC
GGATCCTCAAGCTGCTCGACGCTCAT
pHY77 NdeI
BamHI
pHY83
CWPS1NS1868 WP_078873129 241 CATATGAACACTTCCCTCGCTGC
GAATTCTCAGCGTTCGGCCGCCCGGTC
pHY103 NdeI
EcoRI
pHY107
CWLS1NF5053 WP_051847149 243 CATATGTGCGAGGGCGCCGATGTGC
GGATCCTCAGGATTCGTCCACCGG
pJL03 NdeI
BamHI
pJL26a
CWPS1NF5123 WP_052397358 263 CATATGACCAGCAGGACCGAAAC
GAATTCTCACGGAAGCAGCCGGGGG
pHY100 NdeI
EcoRI
pHY105
CWXS1NS1868 WP_078872750 267 CATATGGCCACACACGCCTCCGC
GAATTCTCACTGCTGCGTCACGTGGTC
pHY101 NdeI
EcoRI
pHY106
CWXS1NB3589 KOG90878 255 CATATGGGGGCCCCGCAGCCC
GGATCCTCACGTCAAGTCCCTTTCTCC
pJL02 NdeI
BamHI
pJL25
CWXS1NB24309 WP_078624487 282 GCGCATATGAGTGCATCGCAGGCTGCTG
GGATCCTCACGTCACGTCCCCTGC
pJL01 NdeI
BamHI
pJL24b
CFLS1NF5639 WP_031028810 278 CATATGAACCGCCGCTGTTCCTTCG
GGATCCTCATGCTCCTGGGGCACTG
pJL04 NdeI
BamHI
pJL29
CFLS1D41684 BAU83478 224 CGCATATGAACCAGTTCGACGTGCTGCC
GGATCCCCGGACCACGAGGAAGCC
pJL05 NdeI
BamHI
pJL30c
Restriction sites for cloning are underlined in primer sequences
a The 12 base pairs at the 5´-end of the sequence coding for WP_051847149 were not included in the expression construct pJL26
b The 96 base pairs at the 5´-end of the sequence coding for WP_078624487 were not included in the expression construct pJL24
c According to the annotation in database, BAU83478 comprises 484 amino acids and consists of CDPS sequence at its N-terminus and that for a
putative methyltransferase at its C-terminus. The sequence coding for amino acids 1 - 224 of BAU83478 was cloned into pET28a generating pJL30
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Table S1 Streptomyces strains used in this study  
Strains Source Cultivation Media 
Streptomyces cattleya DSM 46488 DSMZ GYM 
Streptomyces lavendulae NRRL B-2774 NRRL GYM 
Streptomyces purpureus NRRL B-5737 NRRL ISP4 
Streptomyces xanthophaeus NRRL B-5414 NRRL ISP4 
Streptomyces sp. NRRL S-1868 NRRL ISP4 
Streptomyces sp. NRRL F-5053 NRRL ISP4 
Streptomyces sp. NRRL F-5123 NRRL GYM 
Streptomyces varsoviensis NRRL B-3589 NRRL GYM 
Streptomyces monomycini NRRL B-24309 NRRL GYM 
Streptomyces sp. NRRL F-5639 NRRL ISP4 
Streptomyces laurentii DSM 41684 DSMZ GYM 
DSMZ: Deutsche Sammlung von Mikroorganismen und Zellkulturen 
NRRL: ARS Culture Collection 
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Table S2 The yields (mg/L culture) of the main products of the 11 CDPSs under six different 
conditions 
 
          CDPSs 
Temperature 
-IPTG final conc. 
CWWS1D46488 
(cWW) 
CWWS2D46488 
(cWW) 
CWWS1NB2774 
(cWW) 
CWWS1NB5737 
(cWW) 
CWWS1NB5414 
(cWW) 
20 ℃ - 0.2 mM 77.0 33.7 69.2 18.8 55.1 
20 ℃ - 0.5 mM 88.8 33.7 85.8 24.4 48.8 
30 ℃ - 0.2 mM 88.2 59.1 95.8 41.2 34.3 
30 ℃ - 0.5 mM 95.5 51.8 98.6 63.7 34.5 
37 ℃ - 0.2 mM 81.9 19.5 82.6 9.0 3.4 
37 ℃ - 0.5 mM 89.7 28.5 65.0 11.3 - 
          CDPSs 
 
Temperature 
-IPTG final conc. 
CWPS1NS1868 
(cWP) 
CWPS1NF5123 
(cWP) 
CWXS1NS1868 
(cWA) 
CWLS1NF5053  
(cWL) 
CWXS1NB3589  
(cWY) 
CWXS1NB24309 
(cWY) 
20 ℃ - 0.2 mM 144.9 69.2 69.3 93.9 141.4 51.7 
20 ℃ - 0.5 mM 173.8 85.8 75.5 96.4 111.8 64.7 
30 ℃ - 0.2 mM 131.4 95.8 68.1 104.9 25.8 55.8 
30 ℃ - 0.5 mM 198.2 98.6 74.7 104.2 44.9 54.9 
37 ℃ - 0.2 mM 146.3 82.6 14.7 104.9 94.6 15.5 
37 ℃ - 0.5 mM 128.4 65.0 12.1 84.7 106.1 13.4 
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Table S3 HR-EI-MS data of the CDPS products 
Compound 
Chemical 
Formula 
[M+H]+ 
Deviation (ppm) 
Calculated Measured  
cWA C14H15N3O2 258.1237 258.1224 5.0 
cWY C20H19N3O3 350.1499 350.1495 1.1 
cWM C16H19N3O2S 318.1271 318.1289 -5.7 
cWV C16H19N3O2 286.1550 286.1536 4.9 
cWW C22H20N4O2 373.1659 373.1636 6.2 
cWF C20H19N3O2 334.1550 334.1545 1.5 
cWL C17H21N3O2 300.1707 300.1709 -0.7 
cWP C16H17N3O2 284.1394 284.1417 -8.1 
cFL C15H20N2O2 261.1598 261.1619 -8.0 
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Table S4 1H NMR data of the isolated cyclodipeptides 
 
 
 
 
 
Comp. 
HN
NH
N
H O
O
2
3
9
4
5
6
7
8
10
13
14
1611
H
N
17
18
19
21
22
23
24
2526
1
20
12
15
 
cyclo-(L-Trp-L-Trp) (DMSO-d6) 
HN
NH
N
H O
O
2
3
9
4
5
6 8
10
13
14
16
11
17
18
19
20
21
22
231
12
15
7  
cyclo-(L-Trp-L-Phe) (DMSO-d6) 
HN
NH
N
H O
O
2
39
4
5
6
7
8
10
13
14
16
11
17
18 19
20
1 12
15
 
cyclo-(L-Trp-L-Leu) (CDCl3) 
HN
N
N
H O
O
2
39
4
5
6
7
8
10
13
11
1
14
17
18
19
16
15
12
 
cyclo-(L-Trp-L-Pro) (CDCl3) 
Pos. δH, multi., J [Hz] δH, multi., J [Hz] δH, multi., J [Hz] δH, multi., J [Hz] 
1 
2 
4 
5 
6 
7 
10 
 
11 
12 
14 
15 
17 
 
18 
 
19 
 
20 
21 
22 
23 
24 
25 
10.81, s 
6.61, d, 2.3 
7.35, d, 8.0 
6.95, ddd, 8.0, 7.0, 1.1 
7.04, ddd, 8.1, 7.0, 1.1 
7.28, dt, 8.1, 1.1 
2.71, dd, 14.3, 4.2 
2.20, dd, 14.3, 6.7 
3.87, m 
7.66, d, 2.5 
3.87, m 
7.66, d, 2.5 
2.71, dd, 14.3, 4.2 
2.20, dd, 14.3, 6.7 
- 
- 
6.61, d, 2.3 
- 
10.81, s 
- 
7.28, dt, 8.1, 1.1 
7.04, ddd, 8.1, 7.0, 1.1 
6.95, ddd, 8.0, 7.0, 1.1 
7.35, d, 8.0 
10.90, s 
7.00, d, 2.3 
7.52, dd, 8.0, 1.1 
7.02, ddd, 8.0, 7.0, 1.1 
7.10, ddd, 8.1, 7.0, 1.1 
7.35, dt, 8.1, 1.1 
2.84, dd, 14.5, 5.9 
2.57, m 
4.00, m 
7.90, d, 2.4 
3.89, m 
7.71, d, 2.5 
2.50, m 
1.92, dd, 13.6, 7.1 
- 
- 
6.76, dd, 8.0, 2.0 
- 
7.20a 
7.20a 
7.20a 
6.76, dd, 8.0, 2.0 
- 
- 
8.15, s 
7.11, d, 2.3 
7.63, dd, 8.0, 1.0 
7.15, ddd, 8.0, 7.1, 1.0 
7.23, ddd, 8.2, 7.1, 1.0 
7.39, dt, 8.2, 1.0 
3.49, ddd, 14,7, 3.1, 0.7 
3.21, dd, 14.7, 8.4 
4.32, m 
5.88, s 
3.89, m 
5.86, s 
1.51, m 
1.48, m 
0.98, m 
- 
0.84, d, 6.5 
 
0.81, d, 6.5 
- 
- 
- 
- 
- 
8.55, s 
7.06, d, 2.1 
7.58, dd, 8.0, 1.0 
7.13, ddd, 8.0, 7.0, 1.0 
7.22, ddd, 8.1, 7.0, 1.1 
7.38, dt, 8.1, 1.1 
3.75, ddd, 15.1, 3.8, 1.0 
2.97, dd, 15.1, 10.7 
4.37, ddd, 10.7, 3.8, 1.0 
5.83, s 
4.06, bt, 7.4 
- 
2.31, m 
2.01, m 
1.96, m 
1.89, m 
3.65, m 
3.58, m 
- 
- 
- 
- 
- 
- 
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Table S4 (continued) 
Comp. 
HN
NH
N
H O
O
2
39
4
5
6
7
8
10
13
14
16
11
1712
15
1
 
cyclo-(L-Trp-L-Ala) (CD3OD) 
HN
NH
N
H O
O
2
39
4
5
6
7
8
10
13
14
1611
17
OH
18
19
20
21
22
23 24
1 12
15
 
cyclo-(L-Trp-L-Tyr) (DMSO-d6) 
HN
NH
N
H O
O
2
39
4
5
6
7
8
10
13
14
16
11
S
17
18
20
1 12
15
 
cyclo-(L-Trp-L-Met) (CD3OD) 
HN
NH
N
H O
O
2
39
4
5
6
7
8
10
13
14
16
11
17 18
19
1 12
15
  
cyclo-(L-Trp-L-Val) (DMSO-d6) 
Pos. δH, multi., J [Hz] δH, multi., J [Hz] δH, multi., J [Hz] δH, multi., J [Hz] 
1 
2 
4 
5 
6 
7 
10 
 
11 
12 
14 
15 
17 
 
18 
19 
20 
22 
23 
24 
- 
7.05, s 
7.58, dt, 8.0, 1.0 
6.97, ddd, 8.0, 7.1, 1.0 
7.05, ddd, 8.1, 7.1, 1.0 
7.30, dt, 8.1, 1.0 
3.44, dd, 14.6, 4.1 
3.12, dd, 14.6, 4.5 
4.25, ddd, 4.5, 4.1, 1.3 
- 
3.67, qd, 7.1, 1.2 
- 
0.32, d, 7.1 
- 
- 
- 
- 
- 
- 
- 
10.90, d, 1.5 
7.00, d, 1.5 
7.51, dd, 7.9, 1.0 
7.02, ddd, 7.9, 7.0, 1.0 
7.09, ddd, 8.1, 7.0, 1.0 
7.34, dt, 8.1, 1.0 
2.83, dd, 14.5, 4.2 
2.49b 
3.97, m 
7.80, d, 2.5 
3.81, m 
7.62, d, 2.6 
2.45b 
1.86, dd, 13.6, 4.5 
- 
6.61, dt, 8.6, 2.0 
6.56, dt, 8.6, 2.0 
6.56, dt, 8.6, 2.0 
6.61, dt, 8.6, 2.0 
9.18, s 
- 
7.04, s 
7.59, dt, 8.0, 1.0 
6.96, ddd, 8.0, 7.0, 1.0 
7.05, ddd, 8.1, 7.0, 1.1 
7.30, dt, 8.1, 1.1 
3.47, dd, 14.7, 3.5 
3.09, dd, 14.7, 4.6 
4.27, ddd, 4.6, 3.5, 1.4 
- 
3.77, ddd, 7.4, 4.7, 1.3 
- 
1.17, m 
0.60, m 
1.63, m 
- 
1.73, s 
- 
- 
- 
10.85, s 
7.11, d, 2.4 
7.63, d, 7.9 
6.97, ddd, 7.9, 7.1, 1.0 
7.05, ddd, 8.1, 7.1, 1.0 
7.32, d, 8.1 
3.24, dd, 14.5, 5.0 
3.11, dd, 14.5, 4.5 
4.17, m 
7.96, s 
3.52, m 
7.87, s 
1.68, m 
- 
0.64, d, 7.1 
0.25, d, 6.8 
- 
- 
- 
a, b: Signals with the same letter overlapping with each other 
The data correspond well to those reported for cWA (Caballero et al. 1998), cWY (Kumar et al. 2014), cWV (He et al. 2013), cWL (Kumar et al. 2014), cWW (Giessen et al. 2013a; Lu et al. 2017), 
cWF (Kumar et al. 2014), and cWP(Grundmann and Li 2005), respectively.
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Fig. S1 Phylogenetic tree of known CDPSs from actinobacteria prior to this study 
(Brockmeyer and Li 2017; Giessen et al. 2013a; Giessen et al. 2013b; Jacques et al. 
2015; James et al. 2015) 
 
 NcdA Nocardiopsis sp. CMB-M0232 (cWW) 
 WP_017537615 Nocardiopsis halophila (cWW) 
 Amir 4627 Actinosynnema mirum DSM 43827 (cWW) 
 WP_009073312 Streptomyces sp. AA4 (cWW) 
 WP_014140974 (CWWS2D46488) Streptomyces cattleya DSM 46488 (cWW) 
 WP_027751606 Streptomyces sp. CNH287 (cWW)  
 EPD89497 Streptomyces sp. HPH0547 (cWW) 
WP_014141671 (CWWS1D46488) Streptomyces cattleya DSM 46488 (cWW) 
 WP_011273511 Corynebacterium jeikeium (cLL) 
 NozA Nocardiopsis sp. CMB-M0232 (cWW)) 
 WP_081578182 Austwickia chelonae (cCC, cCA, cCV) 
 WP_024127498 Streptomyces sp. F12 (cCC) 
 EWM10567 Kutzneria sp. 744 (cCC) 
 WP_009082649 Streptomyces sp. AA4 (cCC) 
  WP_050986820 Streptomyces somaliensis (cCC)) 
 AHI00829 Kutzneria albida DSM 43870 (cCC) 
 WP_015099810 Saccharothrix espanaensis (cCC) 
 WP_039919381 Amycolatopsis azurea (cCC) 
 WP_007028561 Amycolatopsis decaplanina (cCC) 
 WP_015033069 Streptomyces venezuelae (cYY) 
 Rv2275 Mycobacterium tuberculosis H37Rv (cYY) 
  WP_078486728 Streptomyces albulus (cFL, cFF, cFY)  
 AlbC Streptomyces noursei (cFL, cFF, cLL) 
 WP_013152196 Nocardiopsis dassonvillei (cFY) 
 WP_017544375 Nocardiopsis prasina (cFY, cYY) 
 WP_007379823 Streptomyces sviceus (cLV) 
 WP_016576960 Streptomyces albulus (cWW) 
 WP_016572541 Streptomyces albulus (cEA, cES) 
 WP_014985896 Nocardia brasiliensis (cEA) 
 WP_007317485 Gordonia effuse (cEA) 
 CDQ44434 Mycobacterium neoaurum (cEA) 
100 
100 
100 
100 
74 
67 
34 
42 
80 
52 
93 
87 
82 
70 
41 
66 
92 
87 
71 
38 
29 
25 
24 
41 
35 
100 
72 
82 
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Fig. S2 1H NMR spectrum of cyclo-(L-Trp-L-Trp) in DMSO-d6 
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Fig. S3 1H NMR spectrum of cyclo-(L-Trp-L-Pro) in CDCl3 
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Fig. S4 1H NMR spectrum of cyclo-(L-Trp-L-Leu) in CDCl3 
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Fig. S5 1H NMR spectrum of in cyclo-(L-Trp-L-Tyr) in DMSO-d6 
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Fig. S6 1H NMR spectrum of cyclo-(L-Trp-L-Phe) in DMSO-d6  
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Fig. S7 1H NMR spectrum of cyclo-(L-Trp-L-Ala) in CD3OD 
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Fig. S8 1H NMR spectrum of cyclo-(L-Trp-L-Met) in CD3OD 
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Fig. S9 1H NMR spectrum of cyclo-(L-Trp-L-Val) in DMSO-d6
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A) E.coli /
 
pET28a (+)
C)
 
E.coli /
 
pJL29 (WP_031028810)
E)
 
E.coli
 
/ pJL30 (BAU83478)
time [minute]
cFL
cFL
0
8 0 0
0 1 0 2 0 3 0
0
2 5 0 0 0 0
5 0 0 0 0 0
0
2 5 0 0 0 0
5 0 0 0 0 0
0
2 5 0 0 0 0
5 0 0 0 0 0
0
8 0 0
0
8 0 0
[mAU]
[mAU]
[mAU]
B) E.coli /
 
pET28a (+), EIC 261.1598 0.01
D) E.coli / (WP_031028810), EIC 261.1598 0.01
F) E.coli / pJL30 (BAU83478), EIC 261.1598 0.01
 
Fig. S10 LC-MS analysis of recombinant E. coli strains with empty vector (A and B) 
and expression constructs (C-F). Black lines are UV absorptions at 258 nm and the red 
lines refer to extracted positive ion chromatograms (EIC).
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ABSTRACT: A cyclo-L-Trp-L-Trp tailoring P450 with novel
function from Streptomyces purpureus was identified by
heterologous expression in S. coelicolor and in vitro assays
the recombinant protein. Structural elucidation revealed that
this enzyme catalyzes the transfer of a guanine moiety to the
indole ring of the cyclodipeptide via a C−N bond. Adduct
products of CDP and guanine are unprecedented in nature,
and CDP modification by coupling with guanine has not been
reported prior to this study.
2,5-Diketopiperazine (DKP) scaffold-containing natural prod-
ucts have gained increasing attention in recent years for their
diverse and interesting biological and pharmacological
activities ranging from antibacterial,1,2 antifungal,3,4 antitu-
mor,5,6 and immunosuppressive7 to anti-inflammatory8 activ-
ities. These compounds were prepared by chemical syn-
thesis9,10 or isolated from natural sources. In nature, cyclo-
dipeptides (CDPs) are biosynthesized by large multimodular
nonribosomal peptide synthetases (NRPSs) or small cyclo-
dipeptide synthases (CDPSs).11−13 CDPSs with typical
polypeptide chains of 200−300 residues hijack aminoacyl-
tRNAs from the ribosomal protein synthetic machinery and
use them as substrates to form CDPs.14 The CDPSs are
genetically associated with a variety of tailoring enzymes, such
as cytochromes P450 (P450s), methyltransferases, and cyclo-
dipeptide oxidases, which has drawn remarkable attention for
identification of new modified CDP derivatives and path-
ways.11 Tryptophan-containing cyclodipeptides (cWXs) are
the richest precursors of DKPs with pharmaceutical interest
due to the various modification possibilities on the indole
ring.9,15 Very recently, several CDPSs that are responsible for
the formation of cWXs have been identified in different
Streptomyces strains, including cWW synthases in S. purpureus,
S. lavendulae, and S. xanthophaeus.16−18 In these strains, the
cWW-forming CDPS gene is located directly upstream of a
putative cytochrome P450 gene with the same orientation.
Both genes are flanked by a putative calcium-binding and YncE
family protein (Figure 1). The three P450 homologues share
sequence identities of more than 75% on the amino acid level
with each other (Table S1). It could be therefore speculated
that these three clusters encode biosynthetic pathways of very
similar DKP derivatives.
P450s constitute a superfamily of ubiquitous hemoproteins
that catalyze a large variety of reactions via a complex multistep
mechanism.19 They are the major biocatalysts in the
biosynthesis of steroids and bile acids as well as in the
metabolism of drugs and xenobiotics.20,21 With extraordinarily
broad substrate spectra and regio- and stereoselectivity, they
also play key roles in the biosynthesis of natural products.19,22
In addition to typical P450 reactions such as hydroxylation and
epoxidation, they also catalyze unusual reactions such as aryl−
aryl coupling, bond cleavage or migration and ring opening,
nitration, or rearrangement.23,24 Until now, several CDP
tailoring P450s have been functionally characterized in the
biosynthesis of mycocyclosin,25 pulcherriminic acid,26 and
(−)-ditryptophenaline.27 They catalyze intramolecular C−C
bond formation of cYY, double N-oxide formation and
aromatization of the DKP ring in cLL, and dimerization of
cWF, respectively.25−27
After identification of cWW as the sole product of the three
CDPSs deposited in Figure 1, we were interested in the
function of the P450 homologues in these clusters, termed in
this study P450NB5737, P450NB2774, and P450NB5414, respectively.
Received: June 30, 2018
Published: August 3, 2018
Figure 1. CDPS- and P450-containing gene clusters from three
Streptomyces strains.
Letter
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Alignments of their sequences with those of known P450s from
bacteria revealed the presence of the three P450 featuring
motifs (Figure S1): (i) the highly conserved A/
G241G242XXT245 motif with Thr as a critical residue for the
H-bonding network22 (this residue is replaced by a Ser in the
CDP tailoring P450s),25 (ii) E280XXR283 motif found in the K
helix with the two invariant Glu and Arg to ensure correct
tertiary structure and stabilization of the heme within the
protein,19 and (iii) G347XXXC351 motif in the heme-binding
loop harboring the invariant and catalytically most important
Cys.22 Phylogenetic analysis of functionally characterized
P450s from bacteria (Figure S2) indicated that the CDP
tailoring P450s of interest distribute in the same subclade as
CYP121 from Mycobacterium tuberculosis, which catalyzes the
intramolecular aryl−aryl coupling of cYY.25 They are also
closely related to P-450mel, CYP158A1, and CYP158A2,
which catalyze dimerization of hydroxynaphthalenes/naphtho-
quinones via aryl−aryl coupling in Streptomyces.28−30 Based on
these bioinformatics results, we speculated initially that
P450NB5737, P450NB2774, and P450NB5414 could also be
responsible for intramolecular or intermolecular aryl−aryl
coupling of cWW.
For functional proof, we chose the cluster from S. purpureus
NRRL B5737 for expression. First, CDPSNB5737 was cloned
alone or together with P450NB5737 into the integrative vector
pSET15231 (Table S2) and expressed in S. coelicolor M1146.32
The transformants were cultivated in GYM liquid media at 28
°C for 7 days. The ethyl acetate extracts of the cell cultures
were subjected to LC−MS analysis (Figure 2). In comparison
to that of the wild-type strain M1146 (Figure 2i), CDPSNB5737
transformant showed the sole product peak with the expected
[M + H]+ ion for cWW (1) at m/z 373.1659 (Figure 2ii),
which is consistent with the results obtained from E. coli
transformants (Scheme 1).16 In the CDPSNB5737 and P450NB5737
coexpressing strain, one additional product peak 2 was
detected by UV 277 nm at 18.5 min, and two additional
product peaks for 2 and 2′ were detected by MS with [M +
H]+ ions at m/z 522.1997 (Figure 2iii). Expression of
CDPSNB5737 alone or together with P450NB5737 in S. coelicolor
M1146 with the replicative vector pPWW5033 led to nearly
identical results (Figure 2iv,v).
To confirm the metabolism of 1 by P450NB5737, we cloned its
coding sequence in pPWW50 and expressed it in S. coelicolor
M1146. As shown in Figure 2vii, neither 1 nor 2 or 2′ was
detected in the transformant with P450NB5737. A 2-day-old
P450NB5737 transformant was then fed with 80 μM of 1 and
cultivated further for 7 days. LC−MS analysis indicated that 1
was completely consumed, and 2 and 2′ with a similar ratio as
in the coexpression transformant of CDPSNB5737 and
P450NB5737 were detected as products (Figure 2iii,viii). In
comparison, feeding 1 into M1146 did not lead to any
conversion to 2 or 2′ (Figure 2vi). These results prove that
cWW produced by CDPSNB5737 was metabolized by P450NB5737
to adduct products with an unknown reaction partner rather
than to intra- or intermolecular coupling products within one
or between two cWW molecules. This was deduced from the
[M + H]+ ion of 1 at m/z 373.1659 and those of 2 and 2′ at
m/z 522.1997.
For structure elucidation, approximate 13 mg of 2 was
isolated from 4 L 7 day-old culture of M1146 transformant
harboring pHY48 for expression of CDPSNB5737 and P450NB5737
in GYM and subjected to NMR analysis including 1H, 13C
APT, DQF-COSY, HSQC, and HMBC (Table S3, Figures
S3−S8). Interpretation of the NMR spectra revealed that a
guanine moiety was attached via its C8′ to N1 of 1, resulting in
the downfield shifting of H2 to δ 7.75 and H7 to δ 8.63 ppm,
respectively. In comparison to those of 1, five additional 13C
signals were detected at δ 156.8 (C2′), 150.0 (C4′), 116.4
(C5′), 161.1 (C6′), and δ 153.1 (C8′), which can be assigned
to those of a guanine residue (Table S3).34,35 The key
correlation between H2 and C8′ in HMBC spectrum
confirmed the connection of the two moieties via N1−C8′
(Scheme 1). The production yield of 2 of the 7 day-old culture
was calculated to be 8 mg/L. Due to the low quantity, the
Figure 2. LC−MS analysis of the expression of CDPS and P450 from
S. purpureus in S. coelicolor M1146. Detection was carried out at UV
277 nm and EIC for [M + H]+ ions of 1 and 2.
Organic Letters Letter
DOI: 10.1021/acs.orglett.8b02051
Org. Lett. 2018, 20, 4921−4925
4922
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structure of 2′ cannot be determined in this study. From the
HR-EIMS data, it could be, however, speculated that 2′ is also
a coupling product of guanine with 1.
Taking the structure information on 2 and the results
obtained from heterologous expression and biotransformation
into consideration, we postulated that P450NB5737 catalyzes a
transfer reaction of guanine (3) to 1 (Scheme 1). To prove this
hypothesis, the coding sequence of P450NB5737 was cloned into
pET28a (+) (Table S2) and expressed in E. coli Rosetta
(DE3). Induction with 0.5 mM IPTG at 18 °C for 20 h and
purification with Ni-NTA agarose resulted in an apparently
homologous protein with a yield of 3.5 mg/L culture (Figure
S9).
Most bacterial P450s belong to a class I redox system
consisting of three separate and soluble proteins, i.e.,
ferredoxin, ferredoxin reductase, and P450.36 Usually, bacterial
P450s, especially those from Streptomyces, also accept electrons
from heterologous redox partners.19 We investigated therefore
the P450NB5737 activity by using commercially available spinach
ferredoxin and ferredoxin-NADP+ reductase for electron
transport. Incubation of the purified P450NB5737 with 1 and 3
in the presence of these redox partners and NADPH led to the
detection of 2 (Figure 3i), which was identified by comparison
of its retention time, UV spectrum, [M + H]+ ion,
fragmentation pattern in MS2 mode with those of the isolated
product described above.
No product formation was observed in negative controls
with heat-inactivated protein, without 1 or 3 (Figures 3ii−iv).
However, only low conversion of approximate 1% was
achieved under the tested condition. Increasing the concen-
tration of ferredoxin, ferredoxin reductase, or both to 5-fold
did not change the conversion yield (data not shown). Using
GTP instead of guanine as donor, a trace of 2 was also
detected (Figure 3v), but only approximately 2.3% of that with
guanine (Figure 3i). It cannot be excluded that this amount
was also a product of 1 with 3 as impurity or hydrolytic
product of GTP.
UV−vis spectroscopic analysis of P450NB5737 in the presence
of sodium dithionite and carbon monoxide37−39 revealed
strong absorption at 415 nm of an inactive form and only a
very weak shoulder peak around 446 nm of the active form
(Figure S10). Addition of DTT to the mixture did not increase
the intensity of the absorption at 446 nm (data not shown). In
the case of TxtE, an atypical P450 catalyzing L-tryptophan
nitration in the biosynthesis of thaxtomin A, the absorption at
447 nm strongly benefited from the added DTT.37 All of these
results indicate the presence of only a small portion of the
active P450NB5737 in the purified protein.
As aforementioned, P450s also catalyze intra- and
intermolecular aryl−aryl coupling via radial intermedi-
ates.25,27−30,40 In analogy, we proposed that the radicals of 1
at N1 and 3 at C8′are key intermediates (Figure 4). In this
hypothesis, the two radicals (compound II) are formed parallel
via oxidation of FeII via FeIII and ferryl-oxo intermediate
(FeIVO, compound I).19 Coupling of the two radicals led to
the formation of 2.
In conclusion, we identified in this study a P450 enzyme
from Streptomyces that catalyzes an unusual coupling reaction
of a cyclodipeptide with a nucleobase, leading to unprece-
dented adducts of cyclodipeptide with guanine. This represents
one additional rare atypical P450 example catalyzing the
coupling of two different substrates.40,41 Intramolecular
carbon−nitrogen bond formation between a sugar and its
aglycone core was reported for StaN, a cytochrome P450 in the
biosynthesis of staurosporine.24,42 Coupling of guanine with
cyclo-L-Trp-L-Trp increases significantly the CDP diversity and
opens new prospective pathway in natural product discovery.
To the best of our knowledge, modification of peptides by a
nucleobase has not been reported prior to this study. Although
P450NB5737 is phylogenetically located closely to CYP121
25 and
Scheme 1. Biosynthesis and Metabolism of cWW in S.
purpureus NRRL B-5737
Figure 3. In vitro enzyme assays of recombinant P450NB5737.
Organic Letters Letter
DOI: 10.1021/acs.orglett.8b02051
Org. Lett. 2018, 20, 4921−4925
4923
 75
near to P-450mel, CYP158A1, and CYP158A2,28−30 it uses
clearly diverse substrates and catalyzes a distinct reaction as
these enzymes. More importantly, this special P450 enzyme is
obviously able to bind two significantly different structures as
substrates and transfer them to radical intermediates for a
coupling reaction. This indicates the presence of novel active
site(s) differing from those of known P450s, which should be
investigated in the future.
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Chem. Soc. Rev. 2012, 41, 6902.
(11) Giessen, T. W.; Marahiel, M. A. Int. J. Mol. Sci. 2014, 15, 14610.
(12) Belin, P.; Moutiez, M.; Lautru, S.; Seguin, J.; Pernodet, J. L.;
Gondry, M. Nat. Prod. Rep. 2012, 29, 961.
(13) Mishra, A. K.; Choi, J.; Choi, S. J.; Baek, K. H. Molecules 2017,
22, E1796.
(14) Jacques, I. B.; Moutiez, M.; Witwinowski, J.; Darbon, E.;
Martel, C.; Seguin, J.; Favry, E.; Thai, R.; Lecoq, A.; Dubois, S.;
Pernodet, J. L.; Gondry, M.; Belin, P. Nat. Chem. Biol. 2015, 11, 721.
(15) Li, S. M. Nat. Prod. Rep. 2010, 27, 57.
(16) Liu, J.; Yu, H.; Li, S.-M. Appl. Microbiol. Biotechnol. 2018, 102,
4435.
(17) Liu, J.; Yu, H.; Li, S.-M. Appl. Microbiol. Biotechnol. 2018, 102,
5787.
(18) Gondry, M.; Jacques, I. B.; Thai, R.; Babin, M.; Canu, N.;
Seguin, J.; Belin, P.; Pernodet, J. L.; Moutiez, M. Front. Microbiol.
2018, 9, 46.
(19) Rudolf, J. D.; Chang, C. Y.; Ma, M.; Shen, B. Nat. Prod. Rep.
2017, 34, 1141.
(20) Guengerich, F. P. Chem. Res. Toxicol. 2001, 14, 611.
(21) Kelly, S. L.; Kelly, D. E. Philos. Trans. R. Soc., B 2013, 368,
20120476.
(22) Podust, L. M.; Sherman, D. H. Nat. Prod. Rep. 2012, 29, 1251.
(23) Zhang, X.; Li, S. Nat. Prod. Rep. 2017, 34, 1061.
(24) Greule, A.; Stok, J. E.; De Voss, J. J.; Cryle, M. J. Nat. Prod. Rep.
2018, DOI: 10.1039/C7NP00063D.
(25) Belin, P.; Le Du, M. H.; Fielding, A.; Lequin, O.; Jacquet, M.;
Charbonnier, J. B.; Lecoq, A.; Thai, R.; Courcon, M.; Masson, C.;
Dugave, C.; Genet, R.; Pernodet, J. L.; Gondry, M. Proc. Natl. Acad.
Sci. U. S. A. 2009, 106, 7426.
(26) Cryle, M. J.; Bell, S. G.; Schlichting, I. Biochemistry 2010, 49,
7282.
(27) Saruwatari, T.; Yagishita, F.; Mino, T.; Noguchi, H.; Hotta, K.;
Watanabe, K. ChemBioChem 2014, 15, 656.
Figure 4. Proposed mechanism for the P450NB5737-mediated
intermolecular coupling reaction of cWW and guanine.
Organic Letters Letter
DOI: 10.1021/acs.orglett.8b02051
Org. Lett. 2018, 20, 4921−4925
4924
 76
(28) Funa, N.; Funabashi, M.; Ohnishi, Y.; Horinouchi, S. J.
Bacteriol. 2005, 187, 8149.
(29) Zhao, B.; Guengerich, F. P.; Bellamine, A.; Lamb, D. C.;
Izumikawa, M.; Lei, L.; Podust, L. M.; Sundaramoorthy, M.; Kalaitzis,
J. A.; Reddy, L. M.; Kelly, S. L.; Moore, B. S.; Stec, D.; Voehler, M.;
Falck, J. R.; Shimada, T.; Waterman, M. R. J. Biol. Chem. 2005, 280,
11599.
(30) Zhao, B.; Lamb, D. C.; Lei, L.; Kelly, S. L.; Yuan, H.; Hachey,
D. L.; Waterman, M. R. Biochemistry 2007, 46, 8725.
(31) Kieser, T.; Bibb, M. J.; Buttner, M. J.; Chater, K. F.; Hopwood,
D. A. Practical Streptomyces Genetics, 2nd ed.; John Innes Foundation:
Norwich, UK, 2000.
(32) Gomez-Escribano, J. P.; Bibb, M. J. Microb. Biotechnol. 2011, 4,
207.
(33) Doumith, M.; Weingarten, P.; Wehmeier, U. F.; Salah-Bey, K.;
Benhamou, B.; Capdevila, C.; Michel, J.-M.; Piepersberg, W.; Raynal,
M.-C. Mol. Gen. Genet. 2000, 264, 477.
(34) Marzilli, L. D.; de Castro, B.; Solorzano, C. J. Am. Chem. Soc.
1982, 104, 461.
(35) Teijeira, M.; Santana, L.; Uriarte, E. Magn. Reson. Chem. 1997,
35, 806.
(36) Hannemann, F.; Bichet, A.; Ewen, K. M.; Bernhardt, R.
Biochim. Biophys. Acta, Gen. Subj. 2007, 1770, 330.
(37) Barry, S. M.; Kers, J. A.; Johnson, E. G.; Song, L.; Aston, P. R.;
Patel, B.; Krasnoff, S. B.; Crane, B. R.; Gibson, D. M.; Loria, R.;
Challis, G. L. Nat. Chem. Biol. 2012, 8, 814.
(38) Omura, T.; Sato, R. J. Biol. Chem. 1964, 239, 2370.
(39) Shenkman, J. B.; Jansson, I. Spectral analyses of cytochrome
P450. In Cytochrome P450 Protocols, 2nd ed.; Phillips, I. R., Shephard,
E. A., Eds.; Humana Press Inc: Totowa, NJ, 2006; pp 11−18.
(40) Lin, H.-C.; McMahon, T. C.; Patel, A.; Corsello, M.; Simon, A.;
Xu, W.; Zhao, M.; Houk, K. N.; Garg, N. K.; Tang, Y. J. Am. Chem.
Soc. 2016, 138, 4002.
(41) Agarwal, V.; El Gamal, A. A.; Yamanaka, K.; Poth, D.; Kersten,
R. D.; Schorn, M.; Allen, E. E.; Moore, B. S. Nat. Chem. Biol. 2014, 10,
640.
(42) Onaka, H.; Asamizu, S.; Igarashi, Y.; Yoshida, R.; Furumai, T.
Biosci., Biotechnol., Biochem. 2005, 69, 1753.
Organic Letters Letter
DOI: 10.1021/acs.orglett.8b02051
Org. Lett. 2018, 20, 4921−4925
4925
 77
S1 
 
Supporting information 
Coupling of Guanine with cyclo-L-Trp-L-Trp Mediated by a 
Cytochrome P450 Homologue from Streptomyces purpureus 
Huili Yu†, Xiulan Xie‡, and Shu-Ming Li†* 
† Institut für Pharmazeutische Biologie und Biotechnologie, Philipps-Universität Marburg, Robert-Koch-
Straße 4, 35037 Marburg, Germany 
‡ Fachbereich Chemie, Philipps-Universität Marburg, Hans-Meerwein-Straße 4, 35032 Marburg, Germany 
 78
S2 
 
Table of Contents 
Experimental Procedures  Page 
 Computer-assisted sequence analysis S3 
 Plasmids, bacterial strains, and culture conditions S3 
 Genetic manipulation, PCR amplification, and gene cloning S3 
 Gene expression S4 
 LC-MS analysis S4 
 Isolation and structural elucidation of P450 product S4-S5 
 Determination of production yield of compound 2 in Streptomyces S5 
 Production and purification of P450NB5737 in E. coli 
UV-Vis spectroscopic analysis of P450NB5737 
S5-S6 
S6 
 In vitro assays of P450NB5737 S6 
 
Supplementary Tables 
 Table S1. Comparison of CDPSs and P450s in three Streptomyces strains S7 
 Table S2. Cloning and expression constructs used in this study. S7 
 Table S3. 1H (500 MHz) and 13C NMR (125 MHz) data of the isolated compound 2 
in DMSO-d6 
S8 
 
Supplementary Figures 
 Figure S1. Alignments of P450s from this study and structurally defined natural 
product P450s from bacteria. 
S9 
 Figure S2. Phylogenetic analysis of P450s from this study and functionally 
characterized P450s from bacteria. 
S10 
 Figure S3. 1H NMR spectrum of compound 2 (DMSO-d6, 500 MHz). S11 
 Figure S4. 13C APT spectrum of compound 2 (DMSO-d6, 125 MHz). S12 
 Figure S5. DQF-COSY spectrum of compound 2 (DMSO-d6, 500 MHz, 500 MHz). S13 
 Figure S6. HSQC spectrum of compound 2 (DMSO-d6, 500 MHz, 125MHz). S14 
 Figure S7. HMBC spectrum of compound 2 (DMSO-d6, 500 MHz, 125MHz). S15 
 Figure S8. Section of HMBC spectrum of compound 2 (DMSO-d6, 500 MHz, 
125MHz). 
S16 
 Figure S9. SDS-PAGE analysis of the purified P450NB5737. 
Figure S10. Spectroscopic analysis of P450NB5737. 
S17 
S17 
 
Supplementary References 
 
S18 
 
 79
S3 
 
Computer-assisted sequence analysis 
Nucleotide and protein sequences used in this study were downloaded from NCBI databases 
(http://www.ncbi.nlm.nih.gov). Protein sequences were compared with each other by using 
BLAST programs (http://blast.ncbi.nlm.nih.gov/). Multiple sequence alignments were performed 
by using the program ClustalW and visualized with ESPript 3.0 
(http://endscript.ibcp.fr/ESPript/cgi-bin/ESPript.cgi) to identify strictly conserved amino acid 
residues (Figure S1). The phylogenetic tree in Figure S2 was created by MEGA version 5.0 
(http://www.megasoftware.net). 
Plasmids, bacterial strains, and culture conditions 
Plasmids and constructs used in this study are listed in Tables S2. E. coli DH5α was used as 
host for cloning and E. coli Rosetta (DE3) for P450 production. Streptomyces strains mentioned 
in Figure 1 and Table S1 were obtained from the ARS Culture Collection (NRRL). S. coelicolor 
M11461 was kindly gifted by Prof. Bibb (John Innes Centre). Recombinant E. coli strains were 
cultivated in liquid/solid LB or TB media containing 100 μg/mL ampicillin, 50 μg/mL apramycin or 
50 μg/mL kanamycin. The Streptomyces strains were maintained at 28 °C in GYM (glucose 4.0 
g/L, yeast extract 4.0 g/L, malt extract 10.0 g/L, agar 15.0 g/L, pH 7.3) or ISP4 media (soluble 
starch 10.0 g/L, K2HPO4 1.0 g/L, MgSO4 •7H2O 1.0 g/L, NaCl 1.0 g/L, (NH4)2SO4 2.0 g/L, CaCO3 
1.0 g/L, trace element solution2 1.0 mL/L, agar 15.0 g/L, pH 7.2.). 
Genetic manipulation, PCR amplification, and gene cloning 
Genetic manipulation in E. coli was carried out according to the protocol by Sambrook and 
Russell.3 Isolation of genomic DNA from Streptomyces was performed as described previously.2 
The genes encoding CDPS and P450 were amplified by PCR from genomic DNA by using 
primers listed in Table S2 and Phusion® High-Fidelity DNA Polymerase from New England 
Biolabs (NEB). The generated PCR fragments were cloned into pGEM-T Easy vector and the 
sequence integrity was confirmed by sequencing. After sequencing, the fragments were cut off 
with the appropriate restriction endonucleases from pGEM-T Easy and ligated into pSET152, 
pPWW50 or pET28a (+) vector. They were digested with the same enzymes, previously. The 
generated plasmids (Table S2) were transformed into S. coelicolor M1146 and E. coli Rosetta 
(DE3) for gene expression and P450 protein production, respectively.  
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Gene expression  
For gene expression, the constructs of CDPSs and P450s were transformed into S. coelicolor 
M1146 by conjugation.2 The exconjugants were selected with 1 mg apramycin and 0.5 mg 
trimethoprim in 1 mL H2O.  The spores of the S. coelicolor M1146 transformants were 
inoculated to 30 mL of GYM liquid media supplied with 30 μg/mL of apramycin in 250 mL baffled 
flask and cultured at 28 °C, 180 rpm for 7 days. In the biotransformation experiments, the 
spores of M1146 harboring the P450 expression plasmid pHY44 were inoculated into GYM 
liquid media (30 μg/mL of apramycin) and cultivated for 2 days. After addition of 80 μM of cWW, 
the bacterial cultures were maintained further for 7 days. 1 mL of culture was extracted with one 
volume of ethyl acetate for three times. The organic phases were combined, evaporated, and 
the residues were afterward dissolved in 30 μL of methanol. 5 μL of such samples were taken 
for LC-MS analysis. 
LC-MS analysis 
The ethyl acetate extracts were analyzed on an Agilent HPLC 1260 series equipped with a 
photo diode array detector and a Bruker microTOF QIII mass spectrometer by using an Agilent 
Eclipse XDB C18 column (5 µm, 4.6 x 150 mm). A linear gradient of 5 -100% acetonitrile in 
water, both containing 0.1% formic acid, in 40 min and a flow rate at 0.25 mL/min were used. 
The column was then washed with 100% acetonitrile containing 0.1% formic acid for 5 min and 
equilibrated with 5% acetonitrile in water for 5 min. The parameters of the spectrometer were 
set as following: electrospray positive ion mode for ionization, capillary voltage with 4.5 kV, 
collision energy with 8.0 eV. 
Isolation and structural elucidation of P450 products 
For isolation of the P450 products, the CDPS and P450 coexpression transformant was 
cultivated on a large scale (4 L) at 28 °C for 7 days. The culture supernatant was extracted with 
equal volume of ethyl acetate for three times. The organic phases were combined, evaporated, 
and dried in a freezing dryer. The extracts were loaded on a silica gel column (45×3.5 cm) filled 
with 120 g silica gel 60 (230-400 mesh, Carl Roth GmbH, Karlsruhe, Germany) and eluted with 
mixtures of CH2Cl2 : MeOH in ratios of 100:2, 100:3, 100:5, 100:10 (1000 mL each). The 
products were detected in the fraction eluted with the mixture of 100:10. Fractions containing 
product 2 was further separated on an Agilent HPLC 1260 series equipped with a photo diode 
array detector by using a semipreparative Multospher 120 RP-18 column (10 x 250 mm, 5 µm) 
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with 30% ACN in water. The flow rate was set to 2.5 mL/min. Finally, 13 mg of 2 was obtained 
as pale yellow powder and subjected to NMR analysis.  
NMR experiments were performed at room temperature on a Bruker AVIII spectrometer 
equipped with a 5 mm BBO cryo probe Prodigy with z-gradient. All spectra were processed with 
MestReNova 5.2.2 (Metrelab Research, S5 Santiago de Compostella, Spain). NMR data and 
spectra of the product 2 were provided as Table S3 and Figures S3-S8, respectively.  
Determination of production yield of compound 2 in Streptomyces  
For quantification, an Agilent HPLC 1200 series equipped with a photo diode array detector and 
the same column with that used in LC-MS was used. A linear gradient of 10 to 100% acetonitrile 
in water without acid in 40 min was followed by 100% acetonitrile for 5 min and 10% acetonitrile 
in water for 5 min. The flow rate was 0.5 mL/min. The absorption at 277 nm was used for 
quantification. 3 mg of compound 2 was dissolved in 250 μL DMSO and used as standard. 2 mL 
culture of the M1146 transformant carrying pHY48 for CDPSNB5737 and P450NB5737 expression 
was extracted with 1 mL ethyl acetate for 3 times. The organic fractions were combined and 
dried. The residue was dissolved in 50 μL of methanol and analyzed on HPLC. The production 
yield was calculated to be 8 mg/L in S. coelicolor M1146. 
Production and purification of P450NB5737 in E. coli 
E. coli Rosetta (DE3) cells harboring pHY99 were cultivated in 50 mL LB media (50 μg/mL 
kanamycin) for 16 h as preculture.   Five milliliters of the preculture were transferred to 500 mL 
TB media (50 μg/mL kanamycin) in 2 L-Erlenmeyer flask and grown at 37 °C, 230 rpm to an 
absorption of 0.6 at 600 nm. The gene expression was induced with 0.5 mM IPTG at 18 °C for 
20 h. The bacterial cultures were harvested by centrifugation (4500 rpm, 15 min, 4 °C) and the 
cells were resuspended in lysis buffer (10 mM imidazole, 50 mM NaH2PO4, 300 mM NaCl, pH 
8.0) with 2–5 mL/g wet weight. Lysozyme from the chicken egg white was added at a final 
concentration of 1 mg/mL and incubated on ice for 30 min. The cells were lysed by sonication 
on ice. Cell debris was removed by centrifugation at 13,000 rpm and 4 °C for 30 min. One-step 
purification of the recombinant His6-tagged protein was performed by using Ni-NTA agarose 
(Macherey-Nagel, Düren, Germany) according to the manufacturer’s instructions. The storage 
buffer was changed to 50 mM Tris-HCl (pH 7.5) containing 15% (v/v) glycerol through a NAP-5 
column (GE Healthcare, Freiburg, Germany), which had been equilibrated with the same buffer. 
The obtained protein was stored frozen at −80 °C. Protein concentration was determined on 
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Nanodrop C 2000 (Thermo Scientific, Braunschweig, Germany) and 3.5 mg/L culture of 
P450NB5737 was obtained. The purity of obtained protein was proven with 12% (w/v) SDS-PAGE 
(Figure S9).  
UV-Vis spectroscopic analysis of P450NB5737 
To measure the typical absorbance of P450 ferrous CO complex after reduction, carbon 
monoxide gas was bubbled into the P450NB5737 solution (10.5 μM in 0.1 M potassium phosphate 
buffer containing 20% glycerol, pH 7.4) for 2 min. After addition of 0.1 mg/mL of sodium 
dithionite, a UV-Vis spectrum between 350 and 550 nm was taken on a Multiskan™ GO 
Microplate Spectrophotometer (Thermo Scientific, Dreieich, Germany) by using Greiner UV-
Star® 96 well plates (Greiner Bio-One GmbH, Frickenhausen, Germany). UV-Vis spectra of 
P450NB5737 without treatment and after addition of sodium dithionite were also taken as controls. 
The spectra are shown in Figure S10.  
In vitro assays of P450NB5737 
P450NB5737 activities toward cWW and guanine or GTP were measured in 50 μL system 
containing 5 µM purified P450NB5737, 1 mM cWW, 0.5 mM guanine or GTP, 1 μM spinach 
ferredoxin (Sigma-Aldrich), 0.1 unit/mL spinach ferredoxin-NADP+ reductase (Sigma-Aldrich), 
and 1 mM NADPH in 50 mM Tris-HCl at pH 7.5. The reaction mixtures were incubated at 30 °C 
for 16 h. The negative controls with heat-inactivated P450NB5737, without cWW or guanine were 
performed under the same conditions. The reactions were stopped by addition of 200 μL MeOH 
each. The supernatants after centrifugation were dried in Speedvac and redissolved in 30 μL 
MeOH. 5 μL of these samples were taken for LC-MS analysis. 
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Table S1. Comparison of CDPSs and P450s in three Streptomyces strains. 
 
Protein (length in aa) of 
Strptomyces purpureus 
NRRL B-5737 
Identity to proteins (length in aa) of (%) Protein function 
Streptomyces lavendulae 
NRRL B-2774 
Streptomyces xanthophaeus 
NRRL B-5414 
 
WP_019889609   (239) WP_078950527   (265)    58 WP_063768158   (273)    58 CDPS (cWW synthase) 
WP_019889608   (398) WP_051841251   (416)    75 WP_031150378   (412)    75 Putative P450 
 
 
 
 
Table S2. Cloning and expression constructs used in this study. 
 
  
Protein Accession  
number 
Primer sequences (5’-3’) pGEM-T 
easy 
construct 
Cloning sites  Expression 
vector 
Expression 
construct 
CDPSNB5737 
WP_ 
019889609 
GCCATATGACTCTCATCGAAGACAC 
TCTAGACTAAGCGGCTCGACGGTCAT pHY40 
NdeI/ XbaI 
NdeI/XbaI 
pPWW50 
pSET152 
pHY42 
pHY43 
P450NB5737 
WP_ 
019889608 
CATATGACCGTCGAGCCGCTTGA 
TCTAGACTACCACAACACCGGCAGCC 
 
CATATGACCGTCGAGCCGCTTGA 
GAATTCTCACCACAACACCGGCAGC 
pHY41 
 
pHY98 
NdeI/XbaI 
 
 
NdeI/EcoRI 
pPWW50 
 
 
pET28a(+) 
pHY44 
 
 
pHY99 
(CDPS+ 
P450)NB5737 
- GCCATATGACTCTCATCGAAGACAC TCTAGACTACCACAACACCGGCAGCC pHY46 
NdeI/XbaI 
NdeI/XbaI 
pPWW50 
pSET152 
pHY47 
pHY48 
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Table S3. 1H (500 MHz) and 13C NMR (125 MHz) data of the isolated compound 2 in DMSO-d6 
 
 
 
 
 
 
N HN
NH
H
N
O
O
1
2
45
6
7
9
8
3
10
11 16
15 19
18
25 24
23
2221
26171413
12
N
NH
HN N
O
1´
5´
7´ 8´
9´
6´ 3´
4´
2´
20
NH2  
 
Pos. δH, multi., J [Hz] δC 
1 
2 
3 
4 
5 
6 
7 
8 
9 
10 a 
10 b 
11 
12 
13 
14 
15 
16 
17 a 
17 b 
18 
19 
20 
21 
22 
23 
24 
25 
26 
1' 
NH2-2'  
3' 
4' 
5' 
6' 
7' 
8' 
9' 
- 
7.75, s 
- 
7.38, d, 7.9 
7.00, dd, 7.6, 2.9 
7.12, t, 7.6 
8.63, d, 8.3 
- 
- 
2.80, dd, 14.4, 4.4 
2.56, dd, 14.4, 5.4 
4.04, t, 4.4 
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Figure S1. Alignments of P450s from this study (blue box) and structurally defined natural product P450s from bacteria. Residues 
are numbered according to the sequence of EryF.4 a: A/G241G242XXT245 motif, the highly conserved residue A/G241, G242 and T245 
are marked with “:”. b: E280XXR283 motif, the strictly conserved residues E280 and R283 are marked with “*”. c: G347XXXC351 motif, 
the strictly conserved residues G347 and C351 are marked with “▲”. 
：：
a b
c * *
▲ ▲
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Figure  S2. Phylogenetic analysis of P450s from this study (  ) and functionally characterized 
P450s from bacteria. Scale bar, 0.2 substitutions per site. The protein sequneces were 
downloaded from NCBI database. 
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Figure  S3. 1H NMR spectrum of compound 2 (DMSO-d6, 500 MHz). 
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Figure S4. 13C APT spectrum of compound 2 (DMSO-d6, 125 MHz).  
 89
S13 
 
N HN
NH
H
N
O
O
1
2
45
6
7
9
8
3
10
11 16
15 19
18
25 24
23
2221
2617
1413
12
N
NH
HN N
O
5'
7' 8
'
9'
6' 3'
4'
2'
20
NH2
2.53.03.54.04.55.05.56.06.57.07.58.08.59.09.510.511.5
f2 (ppm)
3
4
5
6
7
8
9
10
11
f1
 (p
pm
)
1'
 
Figure S5. DQF-COSY spectrum of compound 2 (DMSO-d6, 500 MHz, 500 MHz).  
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Figure S6. HSQC spectrum of compound 2 (DMSO-d6, 500 MHz, 125MHz).  
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Figure S7. HMBC spectrum of compound 2 (DMSO-d6, 500 MHz, 125MHz).  
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Figure S8. Selected region of HMBC spectrum of compound 2 (DMSO-d6, 500 MHz, 125MHz).
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Figure S9. SDS-PAGE analysis of the purified P450NB5737. The proteins were separated on a 12% 
polyacrylamide gel and stained with Coomassie brilliant blue R-250. Lane 1: Protein marker, 
lane 2: purified P450NB5737. 
 
 
                    Figure S10. Spectroscopic analysis of P450NB5737.  
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Abstract Prenyltransferases of the dimethylallyltryptophan
synthase (DMATS) superfamily are involved in the biosyn-
thesis of secondary metabolites and contribute as modification
enzymes significantly to structural diversity of natural prod-
ucts. They show usually broad specificity toward their aromat-
ic substrates with regiospecific prenylations on aromatic rings.
However, most members of this superfamily exhibit a high
specificity toward their prenyl donors and usually accept ex-
clusively dimethylallyl diphosphate (DMAPP). Recently, sev-
eral indole prenyltransferases from this family were also dem-
onstrated to accept unnatural DMAPP analogs such as
methylallyl, 2-pentenyl and benzyl diphosphate for alkylation,
or benzylation of the indole ring. Partial or complete shift of
the substitution position was observed for these enzymes. In
this study, we report the acceptance of these DMAPP analogs
by two tyrosine O-prenyltransferases TyrPT from Aspergillus
niger and SirD from Leptosphaeria maculans for alkylation or
benzylation of tyrosine and derivatives. NMR and mass spec-
trometry (MS) analyses of nine isolated enzyme products con-
firmed the regiospecific O- or N-alkylation or benzylation at
position C-4 of the aromatic ring, which is the same
prenylation position of these enzymes in the presence of
DMAPP.
Keywords DMATS superfamily . Unnatural alkyl donors .
Tyrosine and derivatives . Enzyme catalysis
Introduction
Attachment of a prenyl moiety to an aromatic core plays an
important role for creation of structural diversity of secondary
metabolites (Heide 2009). Prenyltransferases catalyzing such
attachments are found in many living organisms including
plants, bacteria, and fungi and can be classified in different
subgroups based on their amino acid sequences and biochem-
ical properties (Heide 2009; Yazaki et al. 2009; Yu and Li
2012). The members of the dimethylallyltryptophan synthase
(DMATS) superfamily catalyze the transfer reactions of
prenyl moiety from prenyl donors, usually dimethylallyl di-
phosphate (DMAPP), to diverse aromatic substrates (Chooi
et al. 2012; Yu and Li 2012). The resulted prenylated products
often show interesting biological and pharmacological activi-
ties distinct from their non-prenylated precursors, which
makes these enzymes to be interesting biocatalysts for phar-
maceutical and medicinal research (Li 2010; Wollinsky et al.
2012). So far, more than 40 such enzymes have been charac-
terized biochemically by using heterologously overproduced
and purified proteins (Fan et al. 2014; Pockrandt et al. 2014;
Wunsch et al. 2015; Yu and Li 2012). The majority of these
enzymes accepts indole derivatives (Yu and Li 2012), while
several members use tyrosine or nitrogen-free aromatic com-
pounds as natural substrates (Fan et al. 2014; Kremer and Li
2010; Pockrandt et al. 2012, 2014). Until now, two L-tyrosine
prenyltransferases have been identified and characterized bio-
chemically. The first one, SirD, is involved in the biosynthesis
of sirodesmin PL in Leptosphaeria maculans (Fig. 1)
(Gardiner et al. 2004; Kremer and Li 2010). The very recently
identified TyrPT from an unknown biosynthetic pathway in
Aspergillus niger (Fig. 1) showed similar biochemical features
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as SirD (Fan et al. 2014). Both enzymes catalyze the same O-
prenylation of the hydroxyl group at the benzene ring (Fan
et al. 2014; Kremer and Li 2010).
One common feature of the DMATS superfamily enzymes
is their high flexibility toward aromatic substrates. In addition
to tryptophan derivatives, indole prenyltransferases also ac-
cept distinct structures such as hydroxynaphthalenes (Yu
et al. 2011), flavonoids (Yu and Li 2011), or xanthones
(Tarcz et al. 2014) as prenyl acceptors. The tryptophan C4-
(FgaPT2) and C7-prenyltransferase (7-DMATS) have also
been demonstrated to accept tyrosine and derivatives as sub-
strates (Fan et al. 2015; Fan and Li 2014). Similar to the
behavior of indole prenyltransferases, the tyrosine
prenyltransferases SirD and TyrPT also accept a number of
tyrosine derivatives and catalyze the O-prenylation of the hy-
droxyl or N-prenylation of the amino group at the aromatic
rings (Fan et al. 2014; Kremer and Li 2010; Zou et al. 2011).
Furthermore, they also catalyze prenylation reactions of tryp-
tophan and derivatives (Fan et al. 2014; Kremer and Li 2010;
Rudolf and Poulter 2013).
In contrast to their high substrate flexibility for acceptors,
most of the DMATS enzymes show a restricted specificity
toward their prenyl donors, accepting usually DMAPP as
prenyl donor (Yu and Li 2012). Only a few enzymes use
GPP, DMAPP and GPP, or DMAPP, GPP, and FPP as prenyl
donors (Chooi et al. 2010; Pockrandt et al. 2014; Pockrandt
and Li 2013; Tarcz et al. 2014). This feature prohibits their
application as biocatalysts in chemoenzymatic synthesis. To
broaden their specificity for alkyl donors, the acceptance of
the unnatural analogs, methylallyl diphosphate (MAPP), 2-
pentenyl diphosphate (2-pen-PP), and benzyl diphosphate
( b enzy l -PP ) , wa s t e s t e d w i t h two t r yp t ophan
prenyltransferases FgaPT2 and 5-DMATS as well as five cy-
clic dipeptide prenyltransferases BrePT, FtmPT1, AnaPT,
CdpNPT, and CdpC3PT in our laboratory (Liebhold et al.
2012, 2013; Liebhold and Li 2013). Our results demonstrated
that the tested enzymes also used such donors for alkylation or
benzylation. However, the restricted regioselectivity observed
with their natural prenyl donor DMAPP has been broken.
Partial or complete shifts of alkylation or benzylation were
detected in these reactions (Liebhold et al. 2012, 2013;
Liebhold and Li 2013). After availability of SirD and TyrPT,
we decided to tes t the behavior of tyros ine O -
prenyltransferases toward MAPP, 2-pen-PP, and benzyl-PP.
Materials and methods
Chemicals
MAPP, 2-pen-PP, and benzyl-PP were synthesized (Liebhold
et al. 2012; Liebhold and Li 2013) following the protocol
described for geranyl diphosphate (Woodside et al. 1988).
Tyrosine and derivatives used for the enzyme assays were
purchased from Bachem (Bubendorf, Switzerland), Sigma-
Aldrich (Steinheim, Germany), Alfa Aesar (Karlsruhe,
Germany), and TCI (Zwijindrecht, Belgium).
Bacterial strains, plasmids, culture conditions,
overproduction, and purification of His-tagged TyrPT
and SirD
pGEM-T easy used for cloning and pET28a for expression
experiments were obtained from Promega (Mannheim,
Germany) and Novagen (Darmstadt, Germany), respectively.
Escherichia coli XL1 Blue MRF’ (Stratagene, Amsterdam,
the Netherlands) was used as host for cloning and SoluBL21
(Novagen) for expression experiments. They were grown at
37 °C in liquid Luria-Bertani (LB) or Terrific Broth (TB)
medium or on solid LB medium with 1.5 % agar (w/v). For
selection of recombinant E. coli strains, 100 μg mL−1 of am-
picillin or 25 μg mL−1 of kanamycin were used.
In this study, SirD was cloned into pET28a and expressed
under the control of a strong T7 promoter. Taking the former
expression plasmid in pQE70 (pAK2) (Kremer and Li 2010)
as template, the coding region of sirD was amplified with
Expand High Fidelity PCR Kit (Roche Diagnostic,
Mannheim, Germany) by using primers SirD_F (5-
CCATGGCGATGCAGACAGCTCGTCTCTTCC-3) at the
5′-end and SirD_R (5-GCGGCCGCCTGTCTGTAGCGAT
TTGGAT-3) at the 3′-end. The underlined letters represent
the restriction enzyme sites NcoI and NotI, respectively, and
7116 Appl Microbiol Biotechnol (2015) 99:7115–7124
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italic letters indicate the inserted mutations in comparison to
the original gene sequence. PCR amplification was carried out
on an iCycler thermal cycler (BioRad, Munich, Germany)
with annealing temperature at 56 °C. The PCR fragment of
1360 bp was cloned into pGEM-T easy vector and subse-
quently sequenced by Eurofins Genomics (Ebersberg,
Germany) to confirm the sequence, resulting in the plasmid
pHY06. The coding region was then released with NcoI and
NotI and ligated into pET28a vector, which had been digested
with the same enzymes previously. The resulted plasmid
pHY07 was used for overproduction of SirD. pHC16 de-
scribed in a previous publication (Fan et al. 2014) was used
for production of TyrPT.
For gene expression, E. coli SoluBL21 cells harboring
pHY07 or pHC16 were cultivated in a 2000-mL cylindrical
flask containing 1000 mL liquid TB medium supplemented
with kanamycin (25 μg mL−1). After growing at 37 °C to an
absorption of 0.6 at 600 nm, the gene expression was induced
with isopropyl thiogalactoside at a final concentration of
0.8 mM for TyrPT and 0.5 mM for SirD at 30 °C for 16 h.
The bacterial cultures were harvested by centrifugation and
resuspended in lysis buffer (10 mM imidazole, 50 mM
NaH2PO4, 300 mM NaCl, pH 8.0) with 2–5 mL g
−1 wet
weight. Lysozyme from the chicken egg white was added at
a final concentration of 1 mgmL−1. After incubation on ice for
30 min, the cells were sonicated six times for 10 s each at
200 W. To separate the cellular debris from the soluble pro-
teins, the lysate was centrifuged at 13,000 rpm and 4 °C for
30 min. One-step purification of the recombinant His6-tagged
fusion protein by affinity chromatography with Ni-NTA aga-
rose resin (Macherey-Nagel, Düren, Germany) was carried
out according to the manufacturer’s instruction. The protein
was eluted with 250 mM imidazole in 50 mM NaH2PO4 and
300 mM NaCl, pH 8.0. In order to remove imidazole, the
protein fraction was passed through a NAP-5 column (GE
Healthcare, Freiburg, Germany), which had been equilibrated
with 50mMTris-HCl (pH 7.5) containing 15% (v/v) glycerol.
The purified TyrPTand SirD were eluted with the same buffer
as for column equilibration and stored at −80 °C for enzyme
assays. The protein concentration was determined on
Nanodrop C 2000 (Thermo Scientific, Braunschweig,
Germany) and then analyzed on 12 % (w/v) SDS-PAGE
(Laemmli 1970) and stained with Coomassie Brilliant Blue
G-250.
Enzyme assays for TyrPT and SirD
For determination of the TyrPT and SirD activity, the reaction
mixtures (100 μL) contained 50 mM Tris-HCl (pH 7.5),
10 mM CaCl2, 1 mM aromatic substrate (Table 1), 1 mM
DMAPP or analogs, 1.5–5 % (v/v) glycerol, 0–5 % dimethyl
sulfoxide (DMSO), and 20 μg of the purified recombinant
protein. After incubation at 37 °C for 16 h, the reactions were
terminated by addition of 100 μL methanol. Protein was re-
moved by centrifugation at 13,000 rpm for 20 min before
injection on HPLC. Two to four independent assays were
carried out routinely. For determination of kinetic parameters
of DMAPP analogs, 50 mM Tris-HCl (pH 7.5), 10 mM
CaCl2, 40 μg purified recombinant protein, 1 mM L-tyrosine
or 4-amino-L-phenylalanine, and DMAPP analogs at final
concentration of 0.01, 0.02, 0.05, 0.08, 0.1, 0.2, 0.5, 0.8,
1.0, 2.0, and 5.0 mM were used in enzyme assays. The reac-
tion mixtures were incubated at 37 °C for 2 h.
Preparative synthesis of prenylated products for structural
elucidation
The enzyme assays for isolation of enzymatic products
contained 50 mM Tris-HCl (pH 7.5), 10 mM CaCl2, 1 mM
aromatic substrate, 1 mM DMAPP analog, and 2 mg of puri-
fied recombinant protein, in a total volume of 10 mL. The
reaction mixtures were incubated in glass vials at 37 °C for
16 h, and the reactions were terminated by addition of 1 vol-
ume of methanol. After centrifugation at 6000 rpm for 30 min
to precipitate protein, the supernatants were concentrated on a
rotary evaporator at 35 °C to 1–2 mL and used as samples for
separation on HPLC.
HPLC analysis and isolation of enzyme products for structure
elucidation
The enzyme assays of TyrPT and SirD were routinely
analyzed on an Agilent HPLC series 1200 (Agilent,
Böblingen, Germany) by using a Multospher 120 RP-
18 column (250×4 mm, 5 μm C + S Chromatographie
Service, Langerwehe, Germany) at a flow rate of
1 mL min−1. Double-distilled water (solvent A) and
methanol (solvent B) were used as solvents. To analyze
the enzyme products, a linear gradient of 30–100 %
(v/v) solvent B in 20 min was used. The column was
then washed with 100 % (v/v) solvent B for 5 min and
equilibrated with 30 % (v/v) solvent B for another
5 min. Detection was carried out by a Photo Diode
Array detector and illustrated for absorption at 277 nm
in this study.
For structure elucidation, the products were isolated on a
Multospher 120 RP 18 column (250×10 mm, 5 μm) with a
linear gradient of 60–100 % (v/v) of methanol (solvent B) in
water (solvent A) in 60–80 min and a flow rate of
2.5 mL min−1. After each run, the column was then washed
with 100 % (v/v) solvent B for 10 min and equilibrated with
60 % (v/v) solvent B for 10 min. The collected fractions were
evaporated to dryness and subjected to NMR and mass spec-
trometry (MS) analyses.
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NMR and MS analyses
The isolated enzyme products were dissolved in D2O or
CD3OD.
1H NMR spectra were recorded at room temperature
on a JEOL ECA-500 spectometer (JEOL, Tokyo, Japan).
Two-dimensional spectra HSQC and HMBC were recorded
on a Bruker Avance 500 MHz spectrometer (Bruker,
Karlsruhe, Germany). All of the spectra were processed with
MestReNova 6.0.2 (Metrelab Research, Santiago de
Compostella, Spain), and chemical shifts were referenced to
the signal of D2O at 4.79 ppm and that of CD3OD at
3.30 ppm. The NMR data of isolated products are given in
Table 2 and spectra in Figs. S1–S12 in electronic supplemen-
tary material.
The isolated compounds were also analyzed by high-
resolution electron impact mass spectrometry (HR-EI-MS)
on a Micromass Auto Spec spectrometer (Waters, Milford,
MA). The obtained MS data are given in Table 3.
Results
Overproduction and purification of SirD and TyrPT
Expression of sirDwas carried out with the newly constructed
plasmid pHY07 in pET28a. Purification of the overproduced
SirD led to detection of a predominant protein band on SDS-
PAGE (Fig. 2a). With the help of the strong T7 promoter and
cultivation in nutrient-rich TB media, the protein yield was
improved from 2 to 4 mg L−1 bacterial culture. By incubation
of L-tyrosine with DMAPP and 2-pen-PP, the activity of SirD
from the new construct was proven to be nearly the same of
that from the previous construct (data not shown). Therefore,
SirD for enzyme assays presented in this study was obtained
by using pHY07 as expression vector. TyrPT with a protein
yield of 4–6 mg L−1 bacterial culture was overproduced and
purified as described previously (Fan et al. 2014) (Fig. 2b).
Acceptance of the unnatural DMAPP analogs by tyrosine
prenyltransferases
The purified SirD and TyrPTwere firstly assayed with DMAPP
in the presence of tyrosine (1a) and 12 derivatives (2a–13a).
As shown in Table 1, the behaviors of both enzymes for these
substrates were similar to those observed previously (Fan et al.
2014; Zou et al. 2011). In comparison to previous works with
3 (Zou et al. 2011) or 8.6 μg proteins per 100 μL assay (Fan
et al. 2014), 20 μg were used in this study. As expected, sig-
nificantly higher conversion yields were obtained for most
substrates. The acceptance of 1a–13a by TyrPT and SirD
was then tested in the presence of MAPP, 2-pen-PP, and
benzyl-PP as alkyl or benzyl acceptors. After incubation with
TyrPT and SirD under the same conditions, the reaction mix-
tures were analyzed on HPLC (Materials and methods). In
comparison to negative controls with heat-inactivated proteins
(data not shown), product formation was detected in 73 of 78
incubation mixtures (Table 1). Conversion yields of more than
10 % were calculated for 19 enzyme reactions after incubation
Table 1 Product yields of TyrPT and SirD reactions with tyrosine and derivatives in the presence of DMAPP and analogs
Substrate DMAPP MAPP 2-pen-PP benzyl-PP
Conversion (%) Conversion (%) Conversion (%) Conversion (%)
TyrPT SirD TyrPT SirD TyrPT SirD TyrPT SirD
L-Tyrosine (1a) 89.1±6.20 99.3±0.06 21.2±0.72 28.0±2.7 56.6±6.21 44.3±2.90 2.2±0.27 1.3±0.24
4-Amino-L-phenylalanine (2a) 78.1±0.36 66.1±1.38 57.7±1.45 34.8±0.20 46.4±0.52 42.6±2.57 67.2±3.84 54.6±1.54
3-Fluoro-DL-tyrosine (3a) 50.1±0.15 66.5±3.24 13.1±1.15 8.9±0.66 43.9±4.69 20.5±1.23 1.5±0.40 0.4±0.05
3,4-Dihydroxy-L-phenyl-alanine (4a) 100±0.0 88.2±1.28 5.8±0.15 7.3±0.23 30.2±0.18 14.3±0.77 0.4±0.02 0.3±0.10
α-Methyl-L-tyrosine (5a) 98.3±0.03 89.4±0.44 2.9±0.06 16.0±2.11 10.3±0.44 33.5±2.23 0.1±0.02 0.5±0.01
3-Iodo-L-tyrosine (6a) 100±0.0 100±0.0 4.9±0.37 1.1±0.21 12.0±0.89 3.0±0.08 0.2±0.03 0.2±0.04
3,5-Dibromo-L-tyrosine (7a) 20.6±0.30 53.3±4.26 2.8±0.09 0.7±0.15 3.9±0.18 1.4±0.17 0.3±0.08 0.2±0.05
D-Tyrosine (8a) 59.5±0.30 57.6±4.10 0.1±0.04 0.2±0.09 1.7±0.15 0.8±0.08 0.1±0.02 0.2±0.02
3-Amino-3-(4-hydroxyphenyl)-
propanoic acid (9a)
10.1±0.18 8.7±0.04 1.7±0.06 1.6±0.02 1.8±0.14 1.8±0.12 2.0±0.04 2.0±0.23
3-(3,4-Dihydroxyphenyl)-DL-serine (10a) 16.1±0.54 29.9±1.75 0.6±0.04 0.5±0.03 7.1±0.64 1.3±0.38 0.1±0.03 <0.01
DL-m-Tyrosine (11a) 1.4±0.02 0.3±0.02 0.7±0.04 0.6±0.02 0.7±0.06 0.6±0.01 0.8±0.01 0.6±0.02
3,5-Diiodo-L-tyrosine (12a) 2.2±0.14 2.2±0.01 0.1±0.03 0.1±0.01 0.1±0.04 0.2±0.07 0.1±0.01 0.1±0.01
3-Nitro-L-tyrosine (13a) 6.6±0.03 44.9±1.71 0.1±0.01 <0.01 0.1±0.02 <0.01 <0.01 <0.01
DMAPP dimethylallyl diphosphate, MAPP methylallyl diphosphate, 2-pen-PP 2-pentenyl diphosphate, benzyl-PP benzyl diphosphate
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with 20 μg protein at 37 °C for 16 h. Inspection of the HPLC
chromatograms of the reaction mixtures revealed the presence of
one product peak each. HPLC chromatograms of nine selected
enzyme assays are illustrated in Fig. 3.
As given in Table 1, TyrPT and SirD displayed similar
preference for tyrosine and derivatives in the presence of all
three DMAPP analogs. Higher conversion yields were detect-
ed for incubations of TyrPTand SirD in the presence of 2-pen-
PP than MAPP, corresponding to those observed with indole
prenyltransferases (Liebhold et al. 2012, 2013). 1a and 2a
were well accepted by TyrPT and SirD in the presence of
MAPP with conversion yields of more than 20 %, while 1a–
5a were good acceptors for 2-pen-PP. Conversion yields of
more than 20 % were calculated for incubations of 1a–4a with
TyrPT and 1a–3a and 5a with SirD. In comparison to MAPP
and 2-pen-PP, benzyl-PP was a poor donor for both enzymes.
Conversion yields of 67.2 and 54.6 % were detected for 2a
with TyrPT and SirD, respectively. Much lower conversion
yields of less than 3 % were found for other substrates. As
given in Table 1, 2a was accepted as the best substrate by
TyrPT and SirD in the presence of MAPP and benzyl-PP.
Comparable acceptance was observed for 1a and 2a by both
enzymes in the presence of 2-pen-PP. Overall, 2a was the best
or one of the best substrates for both TyrPT and SirD in the
presence DMAPP analogs, which differs clearly from their
preference toward aromatic substrates in the presence of
DMAPP. Using DMAPP as prenyl donor, TyrPT showed
higher activities toward 4a–6a than 2a and SirD accepted 6a
Table 2 NMR data of the isolated products 1b–3b, 1c–5c, and 2d
The spectra were taken on a JEOL ECA-500 spectrometer. Chemical shifts (δ) are given in ppm and coupling constants in hertz
brt broad triplet
* Signals overlapping with ethanol (impurity)
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much better than 2a (Table 1). It seems that the 4-amino group
of 2a had a better interaction with the enzymes in the presence
of the unnatural donors, so that the cation intermediates
(Liebhold et al. 2012) are more stable than in the cases of
other aromatic substrates.
In a previous study, TyrPT and SirD were demonstrated to
be low stereoselective in the presence of DMAPP as prenyl
donor (Fan et al. 2014). D-Tyrosine (8a) was accepted by
TyrPTand SirDwith relative activities of 50 and 30% of those
of 1a, respectively, which was also confirmed in this study
(Table 1). As given in Table 1, 8a was a very poor substrate
for both enzymes in the presence of the three DMAPP ana-
logs, and conversion yields of less than 2 % were detected in
this study. It can be speculated that in the presence of the
unnatural alkyl or benzyl donors, both enzymes had changed
their conformations, so that 8a was much poorly fixed into the
reaction cavities of both enzymes than 1a.
TyrPT and SirD catalyze the same
O-/N-alkylation/benzylation of tyrosine and derivatives
For structure elucidation, nine enzyme products were isolated
on preparative HPLC from the incubation mixtures of TyrPT
and SirD in different combinations of tyrosine and derivatives
with the three DMAPP analogs. 1b–3bwere obtained from the
incubation mixtures of 1a–3a with MAPP, respectively, 1c–5c
from those of 1a–5a with 2-pen-PP, and 2d from that of 2a
with benzyl-PP. The obtained products were subjected to MS
and NMR analyses. Identical 1H NMR spectra of the enzyme
products were obtained from incubation mixtures of TyrPT
and SirD with a given substrate illustrated in Fig. 3 (data not
shown), proving the same function of both enzymes in the
presence of unnatural DMAPP analogs.
Molecular formula deduced from high-resolution electron
impact mass spectrometry (Table 3) proved the nine isolated
products to be monoprenylated or benzylated derivatives of
the respective substrate. Inspection of the 1H NMR spectra
(Figs. S1–S12 in the Supplementary Material) of 1b–3b, 1c–
5c, and 2d revealed the presence of only one product each.
The coupling pattern of the signals for the methylallyl and 2-
pentenyl residues are comparable to those of previously re-
ported compounds with a regular alkyl moiety (Liebhold et al.
2012), proving their attachment in a regular pattern. In com-
parison to those of the respective substrate, the chemical
shifts, number, and coupling pattern of the signals for protons
at the aromatic ring and the side chain of the isolated products
were nearly unchanged and are similar to those of the
prenylated derivatives with DMAPP (Fan et al. 2014;
Kremer and Li 2010; Zou et al. 2011). All these observations
suggested the alkylation at the hydroxyl or amino group of the
aromatic ring. The chemical shifts of H-1’ of the alkyl moie-
ties for products 1b, 1c, 3b, 3c, and 5c between 4.44 and
4.49 ppm in CD3OD and for 4c at 4.61 ppm in D2O proved
unequivocally their attachment to O-atoms (Fan et al. 2014;
Kremer and Li 2010; Zou et al. 2011). In the case of 3,4-
dihydroxy-L-phenylalanine (4a), O-alkylation at position C-3
or C-4 would be possible. The correlations found between
H-1’ and C-4 in the HMBC spectra of 4c (Fig. 4 and
Figs. S9 and S10 in the SupplementaryMaterial) revealed that
the 2-pentenyl moiety was attached to O-atom at position C-4
Fig. 3 HPLC analysis of the incubation mixtures of selected substrates
with TyrPT (left column) and SirD (middle column) as well as the transfer
reactions catalyzed by TyrPT and SirD (right column). The reaction
mixtures contained 20 μg TyrPT or SirD, 1.0 mM of aromatic substrate,
1.0 mM DMAPP analog, 10 mM CaCl2, and 50 mM Tris-HCl (pH 7.5)
and were incubated at 37 °C for 16 h. The illustrated chromatogramswere
recorded at 277 nm. Product yields are given in parentheses after the
product numbers
Table 3 HR-EI-MS data of the isolated enzyme products
Product Formula Calculated
(Mr)
Measured
[M]+
Deviation
(ppm)
1b C13H17NO3 235.1208 235.1215 −3.0
2b C13H18N2O2 234.1368 234.1379 −4.5
3b C13H16FNO3 253.1114 253.1109 2.0
1c C14H19NO3 249.1365 249.1378 −5.2
2c C14H20N2O2 248.1525 248.1530 −2.0
3c C14H18FNO3 267.1271 267.1285 −5.2
4c C14H19NO4 265.1314 265.1323 −3.4
5c C15H21NO3 263.1521 263.1533 −4.6
2d C16H18N2O2 270.1368 270.1384 −5.9
Fig. 2 SDS-PAGE analysis of purified TyrPT-His6 and SirD-His6. The
proteins were separated on a 12 % SDS-polyacrylamide gel and stained
with Coomassie Brilliant Blue G-250. a Purified SirD and b purified
TyrPT; M molecular mass standard
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of the aromatic ring. The chemical shifts of H-1’ of the alkyl
moiety at 3.75 ppm were observed in the spectra of the prod-
ucts 2b and 2c from the incubation mixtures of 2a with MAPP
and 2-pen-PP, proving an N-alkylation in their structures (Fan
et al. 2014; Zou et al. 2011). In the spectrum of 2d from the
incubation mixture of 2a with benzyl-PP, the signals for both
benzene rings have been nearly unchanged and the signal of
the methylene group was detected at 4.43 ppm. These data
proved unequivocally the benzylation of the amino group at
the aromatic ring. In conclusion, both TyrPT and SirD accept-
ed unnatural alkyl/benzyl donors and catalyzed the O-/N-al-
kylation/benzylation of tyrosine and derivatives at the same
position as in the presence of their natural prenyl donor
DMAPP.
Kinetic parameters of TyrPT and SirD toward the unnatural
DMAPP analogs
To compare the catalytic efficiencies of TyrPT and SirD in
the presence of unnatural alkyl or benzyl donors with those
of their natural prenyl donor DMAPP, kinetic parameters
including Michaelis-Menten constant (KM) and turnover
number (kcat) were determined for MAPP and 2-pen-PP by
using 1a as substrate (Table 4 and Figs. S13–S16 in the
Supplementary Material). Due to the low conversions of
benzyl-PP with 1a, its kinetic parameters were obtained from
incubation mixtures with 2a (Table 4 and Figs. S17 and S18 in
the Supplementary Material). MAPP was accepted by both
enzymes with very small KM values, lower than those of 2-
pen-PP, benzyl-PP, and DMAPP. All three unnatural donors
showed much lower turnover numbers than those of DMAPP.
Discussion
As aforementioned, TyrPT and SirD belong to the
prenyltransferases of the DMATS superfamily. Similar to oth-
er members of this family, TyrPT and SirD showed high sub-
strate flexibility toward tyrosine and derivatives and catalyzed
regioselective transfer reactions, i.e., the 4-O- or 4-N-
prenylation (Fan et al. 2014; Kremer and Li 2010; Zou et al.
2011). Both enzymes also accepted tryptophan and deriva-
tives as substrates and mainly catalyzed the C7-prenylation
at the indole ring (Fan et al. 2014; Kremer and Li 2010;
Rudolf and Poulter 2013). In comparison, the tryptophan
C4-prenyltransferase FgaPT2 and C7-prenyltransferase 7-
DMATS also accepted L-tyrosine and a few number of its
derivatives as prenylation substrates, demonstrating the com-
plementary substrate promiscuity of tryptophan and tyrosine
prenyltransferases. However, differing from the two tyrosine
O-prenyltransferases TyrPT and SirD with the same C7-
prenylated product from L-tryptophan, FgaPT2 catalyzed a
C3- and 7-DMATS an O-prenylation of tyrosine, respectively
(Fan et al. 2015; Fan and Li 2014). Similar to most of the
DMATS enzymes, these two enzymes showed strict substrate
specificity toward DMAPP and did not accepted geranyl di-
phosphate as prenyl donor (Kremer and Li 2010) (data for
TyrPT not shown). Acceptance of MAPP, 2-pen-PP, and
benzyl-PP by TyrPTand SirD presented in this study provided
experimental evidence on their substrate promiscuity for
prenyl donor and expanded their potential usage for increasing
the structural diversity of alkylated compounds in the
chemoenzymatic synthesis.
In previous studies, we have demonstrated that several in-
dole prenyltransferases including tryptophan and tryptophan-
containing cyclic dipeptide prenyltransferases used MAPP
and 2-pen-PP as alkyl donors and the tryptophan C4-
Table 4 Comparison of kinetic parameters of TyrPT and SirD toward alkyl/benzyl donors
Donor TyrPT SirD
KM (mM) kcat (min
−1) kcat/KM (min
−1 mM−1) KM (mM) kcat (min
−1) kcat/KM (min
−1 mM−1)
DMAPPa 0.71 41.4 58.3 0.17 60 352.9
MAPPb 0.029±0.0036 0.12±0.013 4.14 0.13±0.025 0.16±0.03 1.23
2-pen-PPb 0.23±0.052 0.20±0.022 0.87 0.22±0.053 0.13±0.004 0.59
benzyl-PPc 0.52±0.022 0.96±0.003 1.85 0.75±0.0021 1.68±0.01 2.24
DMAPP dimethylallyl diphosphate, MAPP methylallyl diphosphate, 2-pen-PP 2-pentenyl diphosphate, benzyl-PP benzyl diphosphate
a Data for DMAPP were adopted from previous studies (Fan et al. 2014; Kremer and Li 2010)
b Data were obtained from four independent assays by using 1a as aromatic substrate
c Data were obtained from two independent assays by using 2a as aromatic substrate
Fig. 4 Selected HMBC correlations observed in 4c
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prenyltransferase FgaPT2 even used benzyl-PP for
benzylation (Liebhold et al. 2012, 2013; Liebhold and Li
2013). These enzymes catalyzed regiospecific and stereospe-
cific prenyl transfer reactions from DMAPP onto indole rings
(Grundmann and Li 2005; Unsöld and Li 2005; Yin et al.
2009, 2010, 2013; Yu and Li 2012). In the presence of the
unnatural DMAPP analogs, the alkylation/benzylation posi-
tions were partially or completely shifted to the neighboring
posit ion, e.g. , from exclusively at C-2 with C2-
prenyltransferases BrePT and FtmPT1 to both C-2 and C-3
(Liebhold et al. 2013). C2- and C3-alkylations with MAPP
and 2-pen-PP were also observed for the three C3-
prenyltransferases AnaPT, CdpNPT, and CdpC3PT
(Liebhold et al. 2013). The alkylation positions of the two
tryptophan prenyltransferases FgaPT2 and 5-DMATS were
partially (in the presence of MAPP) or completely (in the
presence of 2-pen-PP) shifted (Liebhold et al. 2012). The
tryptophan C4-prenyltransferase FgaPT2 catalyzed the
benzylation at C-5 of the indole ring (Liebhold and Li
2013). As shown in Fig. 3, only one enzyme product each
was detected in the incubation mixtures of selected well ac-
cepted substrates and identified as 4-O- or 4-N-alkylated or
benzylated derivative of the respective substrate. This means
that the TyrPT and SirD products with the unnatural DMAPP
analogs carry the alkyl/benzyl moieties at the same position as
their products with the natural donor DMAPP, although alkyl-
ation at other positions of tyrosine and derivatives such as C-3
would be possible. Together with N-acetyl-3-prenyl-L-tyro-
sine, 3-dimethylallyl-L-tyrosine was isolated from
Streptomyces sp. IFM 10937 (Ahmed et al. 2008). Members
of the DMATS superfamily are also able to catalyze a C3-
prenylation of tyrosine or derivatives, as demonstrated very
recently with FgaPT2 and especially with its mutant
FgaPT2_K174F by using L-tyrosine (1a) and 4-amino-L-phe-
nylalanine (2a) as substrates (Fan et al. 2015). This high re-
gioselectivity of TyrPT and SirD toward tyrosine and deriva-
tives with different alkyl donors would be of essential impor-
tance for controlled structure modification.
As mentioned in the BIntroduction^ section, SirD is in-
volved in the biosynthesis of sirodesmin (Fig. 1) (Gardiner
et al. 2004; Kremer and Li 2010) and the genetic context of
TyrPT in A. niger is unknown (Fig. 1) (Fan et al. 2014). As
shown in this and in the previous studies (Fan et al. 2014;
Kremer and Li 2010; Zou et al. 2011), both enzymes display
similar substrate specificities toward donors and acceptors. It
can be speculated that the structures of these two enzymes are
highly conserved. Furthermore, both DMAPP and the tested
DMAPP analogs are placed in their reaction chambers in sim-
ilar positions and undergo similar reactions.
Determination of the kinetic parameters revealed that
TyrPT and SirD showed high affinity to MAPP and 2-pen-
PP (Table 4). However, the turnover numbers of the TyrPT
and SirD reactions with the three unnatural DMAPP analogs
were found between 0.1 and 1.0 min−1, comparable to those of
the cyclic dipeptide prenyltransferases (Liebhold et al. 2013)
and lower than those of tryptophan prenyltransferases with
these DMAPP analogs (Liebhold et al. 2012). The low cata-
lytic efficiency of TyrPT and SirD toward MAPP, 2-pen-PP,
and benzyl-PP should be improved in the future by site-
directed mutagenesis experiments after availability of the
structures of TyrPT or/and SirD.
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Fig. S1 1H NMR spectrum of 1b in CD3OD. 
 
 
Fig. S2 1H NMR spectrum of 2b in D2O. 
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Fig. S3 H-H COSY spectrum of 2b in D2O. 
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Fig. S4 1H NMR spectrum of 3b in CD3OD. 
 
 
Fig. S5 1H NMR spectrum of 1c in CD3OD. 
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Fig. S6 1H NMR spectrum of 2c in D2O. 
 
 
Fig. S7 1H NMR spectrum of 3c in CD3OD. 
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Fig. S8 1H NMR spectrum of 4c in D2O. 
 
 
Fig. S9 HSQC spectrum of 4c in D2O. 
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Fig. S10 HMBC spectrum of 4c in D2O. 
 
 
Fig. S11 1H NMR spectrum of 5c in CD3OD. 
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Fig. S12 1H NMR spectrum of 2d in D2O. 
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 Fig. S13 Determination of kinetic parameters of TyrPT for MAPP in the presence of L-
tyrosine (1a). 
 
Fig. S14 Determination of kinetic parameters of TyrPT for 2-pen-PP in the presence 
of L-tyrosine (1a).
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Fig. S15 Determination of kinetic parameters of SirD for MAPP in the presence of L-
tyrosine (1a). 
 
Fig. S16 Determination of kinetic parameters of SirD for 2-pen-PP in the presence of 
L-tyrosine (1a). 
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 Fig. S17 Determination of kinetic parameters of TyrPT for benzyl-PP in the presence 
of 4-amino-L-phenylalaine (2a). 
 
 
Fig. S18 Determination of kinetic parameters of SirD for benzyl-PP in the presence of 
4-amino-L-phenylalaine (2a). 
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5 Conclusions and future prospects 
In this thesis, the structure diversity of natural/chemoenzymatic products was 
significantly increased by investigation on the CDP formation and further modification in 
Streptomyces as well as by chemoenzymatic synthesis of prenylated tyrosine analogs.  
Initially, thirteen CDPS homologues from eleven Streptomyces strains were 
characterized by heterologous expression in E. coli. Two CDPSs WP_014141671 and 
WP_014140974 from Streptomyces cattleya DSM 46488 were confirmed to form cWW, 
integrity with the known results. Nine new members of CDPSs were identified to 
catalyze the formation of cWX. With high yields of 46 to 211 mg/L E. coli culture, it is 
convenient for future application in synthetic biology. The other two CDPSs 
WP_031028810 from Streptomyces sp. NRRL F-5639 and BAU83478 from 
Streptomyces laurentii DSM 41684 were proven to catalyze the formation of cFL. 
Phylogenetic analysis of the CDPSs in this study with the known CDPSs revealed two 
clades: the relative conserved clade I containing only cWX synthases with the exception 
for cLL synthase and the promiscuous clade II including cWX synthases and cFX and 
cYX synthases.  
Furthermore, one cWW tailoring P450, P450NB5737 from S. purpureus NRRL-B5737, was 
characterized by heterologous expression in S. coelicolor and by in vitro enzyme assays 
with recombinant proteins. It was demonstrated that the cWW formed by CDPSNB5737 
was further modified by P450NB5737, resulting in an adduct of cWW and guanine via a C–
N bond. However, the activity of P450NB5737 is very low in the in vitro assays, possibly 
due to the incorrect state of the purified P450 from E. coli. The modification of peptides 
by a nucleobase is not reported prior to this study. P450NB5737 is one additional example 
of rare atypical P450s that catalyze the coupling of two substrates with distinct 
structures. This indicates the presence of novel active site(s) in the identified enzymes 
differing from those of known P450s, which should be investigated in the future.    
The spectra of prenyl donors of O-prenyltransferases TyprPT and SirD were also 
expanded by testing their acceptance toward the unnatural DMAPP analogs, such as 
MAPP, 2-pen-PP and benzyl-PP. The reactions were performed by incubation of 
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tyrosine and its 12 analogs in the presence of TyrPT and SirD. It was proven that both 
TyrPT and SirD exhibited similar behavior to the unnatural DMAPP analogs as their 
natural prenyl donor DMAPP, catalyzing the O-/N-alkylation/benzylation of tyrosine and 
derivatives. This study increased significantly the diversity of prenylated products by 
chemoenzymatic synthesis.  
For future prospects, the following works can be performed: 
 Coexpression of the genes of cWX-forming CDPSs with those of CDP PTs such 
as CdpC2PT, CdpC3PT, CdpNPT or AnaPT or even other tailoring enzymes 
from different synthetic pathways in engineered heterologous expression system. 
 
 Understanding the catalytic mechanism of P450NB5737 by solving the crystal 
structure of P450NB5737. 
 
 Identification of the extended clusters containing the CDPSNB5737 and P450NB5737 
by heterologous expression in Streptomyces or gene deletion experiments. 
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